SESSION 1 SCHEDULE
Tuesday
SESSION 1: PROGRESS IN TRANSCATHETER VALVE REPLACEMENT AND TREATMENT OF ASCENDING AORTIC DISEASE
x
6:44 AM - 6:50 AM Opening Remarks
  Presenter(s):Frank J. Veith, MD  
  View Slides in PDF      
TRANSCATHETER HEART VALVES
6:50 AM - 6:55 AM

Power Point Presentation with Synched Audio
The Future Of TAVR
  Presenter(s):Martin Leon B. Leon, MD  
  View Slides in PDF      
6:56 AM - 7:01 AM Update On Current State Of Transcatheter Aortic Valve Replacement (TAVR): A Cardiac Surgeon’s View: What Is The Role Of Surgery In Aortic Valve Disease Treatment
  Presenter(s):Ali B. Khoynezhad, MD, PhD  
  View Slides in PDF      
THE ASCENDING AORTA
7:02 AM - 7:07 AM Progress In Endovascular Graft Treatment Of Ascending Aortic Lesions
  Presenter(s):Rodney A. White, MD  
  View Slides in PDF      
7:08 AM - 7:13 AM Progress In Endovascular Combined Devices For Repairing Lesions Of The Ascending Aorta And The Aortic Valve: The Endo-Bentall Concept
  Presenter(s):Ali B. Khoynezhad, MD, PhD  
  View Slides in PDF      
7:14 AM - 7:19 AM Update On Endovascular Treatment Of Ascending Aortic Lesions: What Is Here And What Is On The Horizon
  Presenter(s):Christoph A. Nienaber, MD, PhD  
7:20 AM - 7:25 AM Endovascular Treatment Of Type A Aortic Dissections (TAADs): What Is Here And What Is Coming
  Presenter(s):Ali Azizzadeh, MD  
  View Slides in PDF      
7:25 AM - 7:25 AM Panel Discussion Will Be Combined With Session 2 at 7:56 A.M.
END OF SESSION 1
 
SESSION 2 SCHEDULE
Tuesday
SESSION 2: PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
x
7:26 AM - 7:31 AM Hybrid Repair Of Aortic Arch And Thoracic Aortic Aneurysms Using ThoraFlex (Hybrid) And Relay Devices For Frozen Elephant Trunk (FET) And TEVAR: Indications And Results
  Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD  
  View Slides in PDF      
7:32 AM - 7:37 AM Current Status Of Complete Hybrid Arch Repair With Elephant Trunk And FET: What Does The Future Hold
  Presenter(s):Anthony L. Estrera, MD  
  View Slides in PDF      
7:38 AM - 7:43 AM

Power Point Presentation with Synched Audio
Endovascular Arch Repair With Cook 2- Or 3-Branched Device For Lesions Involving The Entire Aortic Arch: Indications, Contraindications And Results
  Presenter(s):Stephan Haulon, MD  
  View Slides in PDF      
7:44 AM - 7:49 AM

Power Point Presentation with Synched Audio
Update On Relay Branch For Arch Lesion Endovascular Repairs: Advantages, Limitations And Results
  Presenter(s):Vicente Riambau, MD, PhD / Ciro Ferrer, MD, PhD / Martin Czerny, MD  
  View Slides in PDF      
7:50 AM - 7:55 AM

Power Point Presentation with Synched Audio
Total And Partial Aortic Arch Lesion Repairs With The Gore TAG Single Branch Endograft: An Off-The-Shelf (OTS) Device For Revascularizing Arch Branches: Experience To Date, Advantages And Limitations
  Presenter(s):Michael D. Dake, MD  
  View Slides in PDF      
7:56 AM - 8:08 AM Combined Panel Discussion (Sessions 1 and 2)
END OF SESSION 2
 
SESSION 3 SCHEDULE
Tuesday
SESSION 3: PROGRESS IN THE ENDOVASCULAR TREATMENT OF AORTIC DISSECTIONS: REPORTING STANDARDS, CLASSIFICATION SYSTEMS, STABILISE, AND MORE
x
8:08 AM - 8:13 AM New SVS-STS Aortic Dissection Reporting Standards And Classification System: How Are They Different And Better
  Presenter(s):Joseph V. Lombardi, MD  
  View Slides in PDF      
8:14 AM - 8:19 AM

Power Point Presentation with Synched Audio
Update On The STABILISE Concept For Treating Acute And Chronic TBADs By Disrupting The Intimal Flap By Overdilating The Distal Bare Stent: How It Works, Precautions And Results
  Presenter(s):Jean-Marc Alsac, MD, PhD  
  View Slides in PDF      
8:20 AM - 8:25 AM Dual Lumen Interventions To Promote False Lumen Thrombosis In Chronic Aortic Dissections: The FLIRT Procedure: Indications, Technique And Results
  Presenter(s):Christoph A. Nienaber, MD, PhD  
8:26 AM - 8:31 AM DEBATE: Fenestrated And Branched Endovascular Grafts (F/B/EVAR) Are Usually The Best Treatment For Post-Dissection Thoraco-Abdominal Aneurysms (TAAAs)
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
8:32 AM - 8:37 AM DEBATE: There Will Always Be A Need For Open Repair For Post-Dissection TAAAs: In What Circumstances
  Presenter(s):Hazim J. Safi, MD / Anthony L. Estrera, MD  
  View Slides in PDF      
8:38 AM - 8:43 AM Distal Stent-Graft Induced New Re-Entry Tears (SINEs) With TEVAR Treatment Of TBADs: Prevention By Avoiding Oversizing And Ballooning And Using Tapered Endografts
  Presenter(s):Ludovic Canaud, MD, PhD  
  View Slides in PDF      
8:44 AM - 8:49 AM When Is TEVAR The Best Treatment For Marfan Syndrome And Its Complications
  Presenter(s):James H. Black, III, MD  
  View Slides in PDF      
8:50 AM - 8:56 AM Panel Discussion
END OF SESSION 3
 
SESSION 4 SCHEDULE
Tuesday
SESSION 4: MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
x
8:56 AM - 9:01 AM Long-Term Durability Of Open Repair Of Type I-IV TAAAs Remains Excellent: When Should It Be The First Line Treatment And When Should A Hybrid (Endo + Open) Down-Staging Approach Be Used To Improve Outcomes: How To Do The Latter
  Presenter(s):Mark Conrad, MD, MMSc / Richard P. Cambria, MD  
  View Slides in PDF      
9:02 AM - 9:07 AM Lessons Learned From The STABLE I And II Trials: What Are The Advantages And Limitations Of A Distal Bare Stent Combined With A Proximal Covered Stent
  Presenter(s):Joseph V. Lombardi, MD  
  View Slides in PDF      
9:08 AM - 9:13 AM Why Is F/B/EVAR The Best Treatment For Post TBAD TAAAs: Challenges And Results
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
9:14 AM - 9:19 AM Gore TAMBE Endovascular Graft Device For TAAA Repair: How Does It Work: Results To Date, Advantages And Limitations
  Presenter(s):Mark A. Farber, MD  
  View Slides in PDF      
9:20 AM - 9:25 AM How To Predict TAAA Patients Who Should Not Have An Endovascular Repair And How To Minimize Mortality: Age And Mural Thrombus Matter
  Presenter(s):Patrick W. Kelly, MD  
  View Slides in PDF      
9:26 AM - 9:31 AM Improved Aortic Remodeling With TEVAR And A Distal Bare Metal Stent In Acute Complicated TBAD
  Presenter(s):Christoph A. Nienaber, MD, PhD  
9:32 AM - 9:37 AM Embolization Strategies To Achieve False Lumen Thrombosis With False Lumen TAAAs After TEVAR For TBADs
  Presenter(s):Carlos H. Timaran, MD  
  View Slides in PDF      
9:38 AM - 9:43 AM High Failure Rate Of Best Medical Treatment For Intramural Hematoma Mandates Increased Use Of TEVAR: Does This Help Outcomes
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
9:44 AM - 9:54 AM Panel Discussion
9:54 AM - 10:20 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 4
 
SESSION 5 SCHEDULE
Tuesday
SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY AND TREATMENT, EVAR AND EVAS (ENDOVASCULAR ANEURYSM SEALING)
x
10:20 AM - 10:25 AM Current Pros And Cons Of The Nellix EVAS Endograft For AAA Repair: First Update Of The EVAS2 IDE Trial Of The Modified Improved Nellix Endograft
  Presenter(s):Jeffrey P. Carpenter, MD  
  View Slides in PDF      
10:26 AM - 10:31 AM Failing EVARs Are An Emerging Epidemic: Etiology And How Best To Avoid And Treat The Problem
  Presenter(s):Murray L. Shames, MD  
  View Slides in PDF      
10:32 AM - 10:37 AM Diabetes And AAAs: Facts, Clues And Potential Treatment Opportunities
  Presenter(s):Ronald L. Dalman, MD  
  View Slides in PDF      
10:38 AM - 10:43 AM How Does Metformin Work To Slow AAA Growth At The Cellular Level: Could It Be Effective Treatment For Small AAAs: Is It The Reason For Decreased AAA Incidence In Diabetes
  Presenter(s):Kak Khee Yeung, MD, PhD  
  View Slides in PDF      
Moderator(s): Mark A. Adelman, MD / Michel Makaroun, MD  
10:44 AM - 10:49 AM How Should AAA Sac Behavior After EVAR Be Used To Assess Treatment Success And Patient Prognosis
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
  View Slides in PDF      
10:50 AM - 10:55 AM Impact Of AAA Sac Size On EVAR Outcomes Short And Long-Term: Large Size Is Associated With Failure: What To Do About It
  Presenter(s):Carlos H. Timaran, MD  
  View Slides in PDF      
10:56 AM - 11:01 AM Decreased AAA Sac Diameter After EVAR Is Associated With Good Outcomes While Sac Stability Is Not
  Presenter(s):Andres Schanzer, MD  
  View Slides in PDF      
11:02 AM - 11:12 AM Panel Discussion
Moderator(s): Tilo Koelbel, MD, PhD / Michel Makaroun, MD  
11:13 AM - 11:18 AM

Power Point Presentation with Synched Audio
Should Saccular AAAs Be Fixed At A Smaller Diameter Than Fusiform AAAs: How Should AAA Diameter Be Measured To Include The Normal Aorta Or Not
  Presenter(s):Frans L. Moll, MD, PhD  
  View Slides in PDF      
11:19 AM - 11:24 AM In Patients Suitable For EVAR Or Open Repair, Adverse Neck Anatomy (Short, Wide, Angulated) Is Associated With Increased Reintervention And Mortality Rates Equally After Open And Endo Repairs: From The DREAM RCT: How Should This Influence Treatment
  Presenter(s):Jan D. Blankensteijn, MD  
  View Slides in PDF      
11:25 AM - 11:30 AM Why AAA Diameter Is Often Not Enough To Make A Decision Regarding Threshold For Repair Or Re-Treatment After EVAR: What Other Parameters Should Enter Into The Decision
  Presenter(s):S. Rao Vallabhaneni, MD, FRCS  
  View Slides in PDF      
11:31 AM - 11:36 AM Improved AAA Sac Diameter Surveillance After EVAR Using A Home Smart Phone Ultrasound System: Device Description And Why It Will Improve Outcomes
  Presenter(s):Ian Loftus, MD / Roger M. Greenhalgh, MD  
  View Slides in PDF      
11:37 AM - 11:42 AM Key New Developments In Long-Term Evaluation Of EVAR For AAA Treatment
  Presenter(s):Jason T. Lee, MD  
  View Slides in PDF      
11:43 AM - 11:48 AM Long-Term EVAR Outcomes Have Improved Over Time Whereas Open Repair Outcomes Have Remained Stable: A VQI Propensity Study Explains Differing Results Of RCTs And Shows Late Survival Advantage Of EVAR
  Presenter(s):Marc L. Schermerhorn, MD  
  View Slides in PDF      
11:49 AM - 11:59 AM Panel Discussion
12:00 PM - 1:00 PM Lunch Break - Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 5
 
SESSION 6 SCHEDULE
Tuesday
SESSION 6: MORE ABOUT AAAs, EVAR AND THE PUBLISHED UK NICE AAA GUIDELINES AND THEIR IMPACT ON AAA TREATMENT IN THE UK AND ELSEWHERE
x
1:00 PM - 1:05 PM The Scientific Rationale Underlying The AAA NICE Guidelines: A View From A Writing Committee Member
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS  
  View Slides in PDF      
1:06 PM - 1:11 PM Long-Term Results Of The OVER RCT: Pertinence To NICE AAA Guidelines: How Operator Training And Experience Influence EVAR Outcomes
  Presenter(s):Jon S. Matsumura, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM Impact Of NICE Guidelines On AAA Practice In The UK: Decreased Use Of EVAR Is NOT Justified By Recent Data Showing That EVAR Has Better 10-Year Survival Than Open Repair
  Presenter(s):Ian Loftus, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM Are The NICE AAA Guidelines The End Of EVAR In The UK: Why The Guidelines Are Wrong And Can They Be Fixed
  Presenter(s):Richard G.J. Gibbs, FRCS / Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
  View Slides in PDF      
1:24 PM - 1:29 PM What Is Wrong With The NICE AAA Guidelines: Do They Still Limit The Use Of EVAR As In The Draft Guidelines
  Presenter(s):Bijan Modarai, PhD, FRCS  
  View Slides in PDF      
1:30 PM - 1:35 PM Update On What Has Happened With The NICE Guidelines In The UK And Elsewhere: Where Do They Stand In November 2021
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS  
  View Slides in PDF      
1:36 PM - 1:41 PM Impact Of UK NICE AAA Guidelines On Other Countries Served By The European ESVS Guidelines
  Presenter(s):Anders Wanhainen, MD, PhD  
  View Slides in PDF      
1:42 PM - 1:47 PM What Has Been The Impact Of The UK NICE AAA Guidelines In Germany And Elsewhere – Despite Their Flaws
  Presenter(s):Dittmar Boeckler, MD  
  View Slides in PDF      
1:47 PM - 1:52 PM Panel Discussion
END OF SESSION 6
 
SESSION 7 SCHEDULE
Tuesday
SESSION 7: MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC DISSECTIONS AND THORACIC PATHOLOGY; STROKE PREVENTION WITH TEVAR
x
1:52 PM - 1:57 PM Update On Stroke Reduction Strategies With TEVAR: How To Decrease Particulate And Gas Emboli: What Is The STEP 2 Study Telling Us
  Presenter(s):Tilo Koelbel, MD, PhD / Stephan Haulon, MD  
  View Slides in PDF      
1:58 PM - 2:03 PM Advances In Stroke Prevention From TEVAR: How To Decrease Gas And Particulate Emboli: When Should These Methods Be Used
  Presenter(s):Richard G.J. Gibbs, FRCS  
  View Slides in PDF      
2:04 PM - 2:09 PM Update On Value Of Embolic Brain Protection Devices For Proximal TEVAR And TAVR Procedures: When Are They Mandatory
  Presenter(s):Jeffrey P. Carpenter, MD  
  View Slides in PDF      
2:10 PM - 2:15 PM Material Properties Of The Aortic Arch Can Predict Bird Beaking And Type 1A Endoleaks With TEVAR: Will Conformable Endografts With Proximal Adjustable Angle Control Eliminate The Problem
  Presenter(s):Thomas L. Forbes, MD  
  View Slides in PDF      
2:16 PM - 2:22 PM Panel Discussion
END OF SESSION 7
 
SESSION 8 SCHEDULE
Tuesday
SESSION 8: MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NATURAL HISTORY; NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TBADs
x
2:22 PM - 2:28 PM Long-Term Outcomes Of Medically Managed Acute TBADs: How Were Patients Selected For This Treatment
  Presenter(s):Thomas C. Bower, MD  
  View Slides in PDF      
MEGA DEBATE ON TREATMENT OF ACUTE UNCOMPLICATED TBADs
2:29 PM - 2:34 PM

Power Point Presentation with Synched Audio
DEBATE: Many Uncomplicated Acute TBADs Never Need Invasive Interventions And Are Better Treated Medically; How To Select Such Patients
  Presenter(s):Rachel E. Clough, MD, PhD, FRCS  
  View Slides in PDF      
2:35 PM - 2:40 PM DEBATE: With Uncomplicated Acute TBADs, The Case For Waiting 2-6 Weeks From Onset And Then Limiting Aortic Coverage With TEVAR
  Presenter(s):Mark A. Farber, MD  
  View Slides in PDF      
2:41 PM - 2:46 PM DEBATE: With Uncomplicated TBADs, The Case For Early TEVAR With Extensive Aortic Coverage In Most Patients
  Presenter(s):William D. Jordan Jr., MD / Brad Leshnower, MD  
  View Slides in PDF      
2:47 PM - 2:52 PM DEBATE: Early Intervention For Acute TBADs (7-30 Days After Onset) With TEVAR For Acute TBADs Prevents Abdominal Extension Of False Lumen And TAAA Formation
  Presenter(s):Rodney A. White, MD  
  View Slides in PDF      
2:53 PM - 2:58 PM Ideal Timing And Patient Selection Of TEVAR In Acute Uncomplicated TBAD Patients: When Is Medical Treatment Indicated
  Presenter(s):Ali Azizzadeh, MD  
  View Slides in PDF      
2:59 PM - 3:03 PM [SS] Impact Of Cocaine Abuse On The Course Of Acute TBADs And Their Treatment: What Is The Mechanism
  Presenter(s):Frank R. Arko, MD  
  View Slides in PDF      
3:03 PM - 3:08 PM Techniques For And Advantages Of Rerouting A Misplaced TEVAR Which Is Leading To A Growing False Lumen And Malperfusion In Acute TBAD Patients
  Presenter(s):David M. Williams, MD  
  View Slides in PDF      
3:09 PM - 3:14 PM Re-Entry Specific Endovascular Therapy (RESET), i.e., TEVAR Plus Dealing With Re-Entry Tears Improves Outcomes: How To Do It
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
3:15 PM - 3:21 PM Panel Discussion
END OF SESSION 8
 
SESSION 9 SCHEDULE
Tuesday
SESSION 9: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 1
Moderators:Michael R. Jaff, DO  
x
3:22 PM - 3:25 PM Introduction To The Symposium
  Presenter(s):Frank J. Veith, MD  
3:25 PM - 3:29 PM Welcome And Introduction
  Presenter(s):Michael R. Jaff, DO  
3:29 PM - 3:36 PM The Easy And Hard Parts About Running A PERT Program: Lessons Learned
  Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR  
  View Slides in PDF      
3:36 PM - 3:46 PM The Basics Of Pulmonary Embolism: What Is The Role Of The History, Exam, Biomarkers
  Presenter(s):Raghu Kolluri, MD  
  View Slides in PDF      
3:46 PM - 3:54 PM Do We Need An Echo To Manage Acute Submassive PE
  Presenter(s):David M. Dudzinski, MD  
  View Slides in PDF      
3:54 PM - 4:01 PM Advanced Imaging For PE: What Is The Optimal Strategy For The Diagnosis Of Acute And Chronic PE
  Presenter(s):Brian B. Ghoshhajra, MD, MBA  
  View Slides in PDF      
4:01 PM - 4:11 PM Medical Treatment Of PE: When, Why, For How Long, And How Can I Remember
  Presenter(s):Ido Weinberg, MD, MSc  
  View Slides in PDF      
4:11 PM - 4:19 PM Testing For Cancer And Other Hypercoagulable States In PE
  Presenter(s):Rachel Rosovsky, MD, MPH  
  View Slides in PDF      
4:19 PM - 4:26 PM The First Opportunity – The Emergency Physician Algorithm For Acute PE Management
  Presenter(s):D. Mark Courtney, MD  
  View Slides in PDF      
4:26 PM - 4:33 PM Ultrasound-Assisted Pharmacomechanical Thrombectomy: Does This Really Work
  Presenter(s):Kush R. Desai, MD  
  View Slides in PDF      
4:33 PM - 4:40 PM Mechanical Thrombectomy: The Indigo System
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
  View Slides in PDF      
4:40 PM - 4:50 PM What Strategy Is Best For Acute PE Intervention
  Presenter(s):Patrick Troy, MD  
  View Slides in PDF      
4:50 PM - 4:57 PM Step-By-Step Technical Tips For Pharmacomechanical Intervention For PE
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
4:57 PM - 5:04 PM Percutaneous Mechanical Thrombectomy: The Flowtriever System: Where Does This Fit
  Presenter(s):Mitchell D. Weinberg, MD  
  View Slides in PDF      
END OF SESSION 9
 
SESSION 10 SCHEDULE
Tuesday
SESSION 10: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Moderators:Michael R. Jaff, DO  
x
5:04 PM - 5:11 PM Low-Dose Systemic Lytics: Is This An Effective Strategy For Acute PE Treatment
  Presenter(s):Mohsen Sharifi, MD  
  View Slides in PDF      
5:11 PM - 5:18 PM Vortex Strategy For Massive PE
  Presenter(s):Christopher J. Kwolek, MD, MBA  
  View Slides in PDF      
5:18 PM - 5:26 PM ECMO And Surgical Thromboembolectomy For Massive PE: When, How, And Why
  Presenter(s):Mark G. Davies, MD  
  View Slides in PDF      
5:26 PM - 5:36 PM Putting It All Together: What Is The Modern Algorithm For Management Of Massive And Submassive PE
  Presenter(s):Ido Weinberg, MD, MSc  
  View Slides in PDF      
5:36 PM - 5:43 PM Vena Cava Filters In PE Treatment: Do We Need To Do This, And If So, When
  Presenter(s):Kush R. Desai, MD  
  View Slides in PDF      
5:43 PM - 5:50 PM Balloon Angioplasty For Chronic Thromboembolic Pulmonary Hypertension: Has This Become Mainstream
  Presenter(s):Kenneth Rosenfield, MD  
  View Slides in PDF      
5:50 PM - 5:58 PM The Team Approach To PE Management: The National PERT Consortium
  Presenter(s):William B. Keeling, MD  
  View Slides in PDF      
Moderator(s): Michael R. Jaff, DO  
5:58 PM - 6:15 PM Challenging Cases And “PERT” Decisions” Decisions
  Panelist(s): Mark G. Davies, MD / Kush R. Desai, MD / Ziv J. Haskal, MD, FACR, FAHA, FSIR / William B. Keeling, MD / Christopher J. Kwolek, MD, MBA / Kenneth Rosenfield, MD / Mohsen Sharifi, MD / Ido Weinberg, MD, MSc  
6:15 PM - 6:15 PM End of Program A
END OF SESSION 10
 
SESSION 11 SCHEDULE
Tuesday
SESSION 11: PROGRESS IN VASCULAR ROBOTICS, GUIDANCE SYSTEMS, LAPAROSCOPY AND SIMULATION
x
6:44 AM - 6:49 AM Opening Remarks
  Presenter(s):Enrico Ascher, MD  
  View Slides in PDF      
6:50 AM - 6:55 AM Update On Endovascular Robotics: They Have A Promising Future
  Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS, FACS  
  View Slides in PDF      
6:56 AM - 7:01 AM Robotic Decompression Of The Median Arcuate Ligament
  Presenter(s):Michael J. Singh, MD  
  View Slides in PDF      
7:02 AM - 7:07 AM Laparoscopic Assisted Aortofemoral Bypasses For Juxtarenal Aortic Occlusions: Why It Is The Best Treatment Method
  Presenter(s):Joseph S. Giglia, MD  
  View Slides in PDF      
7:08 AM - 7:13 AM Laparoscopic Robotic Assisted Aortic Surgery: Is It Worthwhile And Cost Effective In The Endovascular Era: Based On A 7-Year Experience In 87 Patients
  Presenter(s):Pierre-Olivier Thiney  
  View Slides in PDF      
7:14 AM - 7:19 AM Present Status And Future Potential Of Radiation Free Guidewire And Catheter Guidance: The Fiber Optic RealShape (FORS) From Philips: What Are Microbots And How Do They Work
  Presenter(s):Barry T. Katzen, MD  
  View Slides in PDF      
7:20 AM - 7:25 AM Update On The 3D Radiation Free Intraoperative Positioning System (IOPS) From Centerline For Endovascular Guidance: How Does It Work, Advantages And Limitations
  Presenter(s):Matthew J. Eagleton, MD  
  View Slides in PDF      
7:26 AM - 7:32 AM Panel Discussion
END OF SESSION 11
 
SESSION 12 SCHEDULE
Tuesday
SESSION 12: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
x
7:32 AM - 7:37 AM Variations In Carotid Treatment Within Countries And Between Countries In Europe, The US And Australia Is Great Despite All The RCTs: What Are The Implications
  Presenter(s):Maarit Venermo, MD, PhD  
  View Slides in PDF      
7:38 AM - 7:43 AM What Vascular Surgeons And Vascular Specialists Need To Know About What Can Be Learned From MRI And MRA Studies Of The Head And Neck
  Presenter(s):Allan L. Brook, MD  
  View Slides in PDF      
7:44 AM - 7:49 AM Update On Isolated Carotid Webs As A Cause Of Cryptogenic Stroke: How To Diagnose And Treat
  Presenter(s):Clayton J. Brinster, MD / W. Charles Sternbergh III, MD  
  View Slides in PDF      
DIFFERING VIEWS ON TREATMENT OF ACS
7:50 AM - 7:55 AM

Power Point Presentation with Synched Audio
DEBATE: ALL Asymptomatic Carotid Stenosis (ACS) Patients Are Best Treated Medically: Invasive Treatment Causes More Harm Than Good
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Slides in PDF      
7:56 AM - 8:01 AM DEBATE: Not So: About 25% Of ACS Patients Can Benefit From CEA Or CAS And Should Be So Treated
  Presenter(s):Bruce A. Perler, MD, MBA  
  View Slides in PDF      
8:02 AM - 8:07 AM DEBATE: Both Views Are Wrong: About 5-10% Of ACS Patients Should Be Treated Invasively And Benefit From Such Treatment: Why Are Too Many ACS Patients Getting CEA Or CAS
  Presenter(s):Kosmas I. Paraskevas, MD  
  View Slides in PDF      
DIFFERING VIEWS ON CAROTID SCREENING
8:08 AM - 8:13 AM DEBATE: The Case For Widespread Carotid Screening
  Presenter(s):George S. Lavenson, MD  
  View Slides in PDF      
8:14 AM - 8:19 AM

Power Point Presentation with Synched Audio
DEBATE: The Case Against Carotid Screening: It Leads To Unneeded And Possibly Harmful Treatment
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Slides in PDF      
8:20 AM - 8:25 AM DEBATE: Lifeline Proprietary Carotid Screening: Who Profits: Is It A Good Thing Or A Hoax And A Scam: What Can It Tell Us About The Prevalence Of ACS
  Presenter(s):James F. Meschia, MD / Thomas G. Brott, MD  
  View Slides in PDF      
8:26 AM - 8:32 AM Panel Discussion
END OF SESSION 12
 
SESSION 13 SCHEDULE
Tuesday
SESSION 13: MORE ABOUT CAROTID AND VERTEBRAL DISEASE: UPDATE ON INVASIVE TREATMENT FOR ACUTE STROKES
x
8:32 AM - 8:37 AM Endovascular Treatment Of Carotid Artery Aneurysms Of Etiologies: Technical Aspects
  Presenter(s):Klaus D. Mathias, MD  
  View Slides in PDF      
8:38 AM - 8:43 AM When After Thrombolysis Treatment From A Stroke Should Carotid Endarterectomy (CEA) Be Performed And What Is The Best Timing For Those CEAs: Delay Has Consequences
  Presenter(s):Maarit Venermo, MD, PhD  
  View Slides in PDF      
8:44 AM - 8:49 AM Why Vascular Surgeons Should Become Involved In Intracranial Endovascular Treatments For Acute Strokes: How To Learn These Procedures And Benefit Patients
  Presenter(s):Laura Capoccia, MD, PhD  
  View Slides in PDF      
8:50 AM - 8:55 AM What Is New With Endovascular Intracranial Techniques For Arterial Clot Removal For Acute Strokes: New Methods; When And How Can The Time Window For Success Be Increased
  Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD  
  View Slides in PDF      
8:56 AM - 9:01 AM Update And New Developments In Intracranial Endovascular Treatment For Acute Strokes: Should Other Specialists Learn How To Do It And The Ways To Learn
  Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD  
  View Slides in PDF      
9:02 AM - 9:07 AM Improvements In The Treatment Of Acute Strokes: Why A Dedicated Stroke Center Matters: What And Who Must Be Involved: Yes, It Does Matter In Better Patient Outcomes
  Presenter(s):Hernan A. Bazan, MD, DFSVS, FACS  
  View Slides in PDF      
9:08 AM - 9:14 AM Panel Discussion
9:14 AM - 9:24 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 13
 
SESSION 14 SCHEDULE
Tuesday
SESSION 14: PROGRESS IN THE TREATMENT OF AORTIC AND AORTO-ILIAC OCCLUSIVE DISEASE
x
9:24 AM - 9:29 AM Current Concepts And Techniques For Treating External Iliac Artery Endofibrosis In Committed Athletes: What Works And Doesn’t Work: Is There A Role For Endovascular Treatment
  Presenter(s):Kenneth J. Cherry, MD  
  View Slides in PDF      
9:30 AM - 9:35 AM

Power Point Presentation with Synched Audio
Iliac Stenosis In Professional Cyclists: How To Diagnose And Treat: ABIs Don’t Help
  Presenter(s):Gabriel Szendro, MD  
  View Slides in PDF      
9:36 AM - 9:41 AM

Power Point Presentation with Synched Audio
Value Of VBX Balloon Expandable Covered Stents In Treating Complex Aorto-Iliac Occlusive Disease: Advantages And Limitations
  Presenter(s):Ehrin Armstrong, MD  
COVERED ENDOVASCULAR RECONSTRUCTION OF THE AORTIC BIFURCATION (CERAB) PROCEDURE
9:42 AM - 9:47 AM 5-Year Outcomes Of The CERAB Procedure With Covered Stents For Complex Aorto-Iliac Occlusive Disease: Why It’s Better Than Kissing Stents And Which Covered Stent Works Best
  Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD  
  View Slides in PDF      
9:48 AM - 9:53 AM CERAB Procedure Versus Kissing Stents For Complex Aorto-Iliac Occlusive Diseases: Advantages And Disadvantages Of Each: CERAB Requires More Time And Radiation
  Presenter(s):Maria A. Ruffino, MD, EBIR  
  View Slides in PDF      
9:54 AM - 9:59 AM Covered Endovascular Reconstruction Of The Aortic Bifurcation (CERAB) Technique: Multicentre UK Experience
  Presenter(s):Hany M. Zayed, MD  
  View Slides in PDF      
10:00 AM - 10:05 AM

Power Point Presentation with Synched Audio
Value Of Shockwave Intravascular Lithotripsy For Calcified Aorto-Iliac Occlusive Disease Treatment
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
10:06 AM - 10:12 AM Panel Discussion
10:12 AM - 10:17 AM Treatment Of Isolated Aortic Stenosis Without Iliac Disease: When Stents; When Stent-Grafts; When Open Bypass
  Presenter(s):Sigrid Nikol, MD  
  View Slides in PDF      
10:18 AM - 10:23 AM DEBATE: How To Treat Chronic Flush Juxtarenal Aortic Occlusions Endovascularly With Safety: Endo Is The Way To Go
  Presenter(s):David J. Minion, MD  
  View Slides in PDF      
10:24 AM - 10:29 AM DEBATE: Not So: Open Surgery Is the Best Way To Treat Flush Juxtarenal Aortic Occlusions Safely: Technical Tips On How To Do It
  Presenter(s):Thomas C. Bower, MD  
  View Slides in PDF      
10:30 AM - 10:35 AM DEBATE: Both Wrong: Hybrid Repairs Are Best For Complex Aorto-Iliac Occlusive Disease: Technical Tips On How To Do It
  Presenter(s):Yamume Tshomba, MD  
  View Slides in PDF      
10:36 AM - 10:42 AM Panel Discussion
END OF SESSION 14
 
SESSION 15 SCHEDULE
Tuesday
SESSION 15: HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE
x
10:42 AM - 10:47 AM Key Steps For Success With Radial Artery Access For Remote Visceral, Renal Or Lower Extremity Lesion Treatment
  Presenter(s):Marcelo Guimaraes, MD, MBA, FSIR  
  View Slides in PDF      
10:48 AM - 10:53 AM DEBATE: CO2 As A Contrast Agent Is Valuable For Lower Extremity Angiography And Treatments If Used Appropriately
  Presenter(s):Palma M. Shaw, MD, FACS, RPVI, DFSVS  
  View Slides in PDF      
10:54 AM - 10:59 AM DEBATE: Not So: CO2 As A Lower Extremity Contrast Agent Is Unnecessary And Has Downsides
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
  View Slides in PDF      
11:00 AM - 11:05 AM Value Of Tack Optimized Balloon Angioplasty In Lower Extremity Interventions: When Should They Be Used And When Not (Tacks From Intact Vascular)
  Presenter(s):Lawrence A. Garcia, MD  
  View Slides in PDF      
11:06 AM - 11:11 AM Heel Ulceration And Ischemic Gangrene Involving The Achilles Tendon Should Not Be An Indication For A BTK Amputation: How To Save Such A Limb
  Presenter(s):Mark G. Davies, MD  
  View Slides in PDF      
11:12 AM - 11:17 AM Popliteal Artery-To-Distal Bypass For Limb Salvage; Status In 2021: Technical Tips And Value: When Is It Better Than Endovascular Treatments Francesco Spinelli, MD
  Presenter(s):Francesco Spinelli, MD  
  View Slides in PDF      
11:18 AM - 11:24 AM Panel Discussion
END OF SESSION 15
 
SESSION 16 SCHEDULE
Tuesday
SESSION 16: MORE HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CHRONIC LIMB THREATENING ISCHEMIA (CLTI) (4 3/4-MINUTE TALKS)
x
11:24 AM - 11:29 AM Value Of External Duplex Ultrasound And Other Technical Factors In Optimizing BTK DCB Angioplasty
  Presenter(s):Francesco Liistro, MD  
  View Slides in PDF      
11:29 AM - 11:34 AM

Power Point Presentation with Synched Audio
How To Size Lower Extremity Target Arteries For Endo Treatments Accurately Using Intravascular Ultrasound (IVUS): Why It Is Important
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Slides in PDF      
11:34 AM - 11:39 AM Patterns Of Calcification In BTK Arteries: How They Influence Endovascular Treatments
  Presenter(s):Jihad A. Mustapha, MD  
  View Slides in PDF      
11:39 AM - 11:44 AM How To Do Bypass Surgery To Heavily Non-Compressible Calcified Target Arteries
  Presenter(s):Enrico Ascher, MD / Frank J. Veith, MD  
  View Slides in PDF      
11:44 AM - 11:49 AM Challenge Of Getting Endovascular Revascularization To Achieve Healing Of Ischemic Wounds: Value Of A Wound Center In A Limb Salvage Program
  Presenter(s):Robert B. McLafferty, MD, MBA  
  View Slides in PDF      
11:49 AM - 11:54 AM

Power Point Presentation with Synched Audio
Lower Extremity Interventions (PTA, Stents, Atherectomy) Under IVUS Guidance: Its Costs, Value And Limitations
  Presenter(s):Ignacio Escotto, MD  
  View Slides in PDF      
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 AM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 16
 
SESSION 17 SCHEDULE
Tuesday
SESSION 17: NEW CONCEPTS, MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE (AI)
x
1:00 PM - 1:05 PM What Is The Bright Future Of AI And Robotic Technology In Vascular Surgery
  Presenter(s):Willem Wisselink, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM Unconventional Renal Allograft Landing Sites (Venous Anastomoses) In The Presence Of Near Total Caval Thrombosis
  Presenter(s):Robert A. Montgomery, MD, D.Phil  
  View Slides in PDF      
1:12 PM - 1:17 PM How Vascular Treatment Will Intersect With Other New Technologies: Wearable Trackers, AI, And Tissue Engineering
  Presenter(s):David H. Deaton, MD, FACS  
  View Slides in PDF      
1:18 PM - 1:23 PM How 3D And 4D Machine Learning Is Changing Vascular Surgery
  Presenter(s):Matthew T. Menard, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM How Can AI Be Used To Predict Endoleaks And AAA Growth: Will It Have Clinical Value
  Presenter(s):Kak Khee Yeung, MD, PhD  
  View Slides in PDF      
1:30 PM - 1:35 PM Siemens I-Flow: A New Intelligent Technology To Improve The Endo Treatment Of Lower Extremity Occlusive Disease
  Presenter(s):Ravi K. Veeraswamy, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM Totally Radiation Free Deployment Of A Complex AAA Endograft Using An Intraoperative Positioning System (IOPS From Centerline) And Positional Markers On Graft Components As Well As Catheters And Wires To Enable Accurate 3D Guidance: It Is Analogous To Precise GPS Targeting
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
1:42 PM - 1:54 PM Panel Discussion
END OF SESSION 17
 
SESSION 18 SCHEDULE
Tuesday
SESSION 18: VASCULAR SURGERY’S NUMBERS, IDENTITY, RECOGNITION, INDEPENDENT SPECIALTY STATUS; HOW TO INCREASE OUR NUMBERS TO MEET FUTURE NEEDS FOR OUR SERVICES
x
1:54 PM - 1:59 PM Updated Workforce Model Predicts A Shortage Of Vascular Surgeons For The Next 20 Years: What Should Vascular Surgery And The American Board of Surgery (ABS) Do About It
  Presenter(s):Bhagwan Satiani, MD, MBA / K. Craig Kent, MD  
  View Slides in PDF      
2:00 PM - 2:05 PM What Makes Vascular Surgery Different, Why Are There Insufficient Numbers Of Vascular Surgeons: How Can We Expand Our Numbers
  Presenter(s):Evan C. Lipsitz, MD, MBA  
  View Slides in PDF      
2:06 PM - 2:11 PM The Clouded Identity Of Vascular Surgery Amongst Other Doctors And The Public: Why Is It So And What Can Be Done About It
  Presenter(s):James C. Stanley, MD / Frank J. Veith, MD  
  View Slides in PDF      
2:12 PM - 2:17 PM Why US News & World Report Cannot And Does Not Rank Vascular Surgery Programs: Vascular Surgery Needs To Be An Independent ABMS Approved Specialty: Why Isn’t It
  Presenter(s):James H. Black, III, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM The American Board Of Vascular Surgery Or ABVS: Its Time Is Now
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
  View Slides in PDF      
2:24 PM - 2:29 PM The SVS Executive Committee: What Is Its Function And How Has It Not Promoted Vascular Surgery And Thereby Failed To Serve Its Membership’s Interests
  Presenter(s):Benjamin W. Starnes, MD  
  View Slides in PDF      
2:30 PM - 2:35 PM What Will Happen If Vascular Surgery Does Not Become A Separate Specialty: How Have Our Vascular Societies Failed Vascular Surgeons
  Presenter(s):David H. Deaton, MD, FACS  
  View Slides in PDF      
2:36 PM - 2:41 PM Why Vascular Surgery Must Be An Independent Specialty: It Needs Independent Departments So As To Not Be Exploited By Other Department Chairs
  Presenter(s):Patrick J. Geraghty, MD  
  View Slides in PDF      
2:42 PM - 2:47 PM The Key To More Vascular Surgeons Is Better Exposure To Medical Students: We Are A Hidden Specialty Because Of Our Subordinate Specialty Status Which Also Limits Our Training Programs
  Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd  
  View Slides in PDF      
2:48 PM - 2:53 PM Vascular Surgery Training Program’s Update For 0+5 And 5+2 Programs: Do We Need More Applicants Or More Programs Or Both: How Can We Get There
  Presenter(s):Murray L. Shames, MD  
  View Slides in PDF      
2:54 PM - 2:59 PM Is Getting A Vascular Surgery Training Position Becoming Less Competitive For 0+5 Residencies; For 5+2 Fellowships
  Presenter(s):Peter L. Faries, MD, FACS  
  View Slides in PDF      
3:00 PM - 3:05 PM Leadership Roles Vascular Surgeons And Vascular Specialists Should Seek: Why They Are Important And How To Get There Without Abandoning Your Original Specialty
  Presenter(s):Christopher J. Kwolek, MD, MBA  
  View Slides in PDF      
3:06 PM - 3:18 PM Panel Discussion And Break
Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 18
 
SESSION 19 SCHEDULE
Tuesday
SESSION 19: PROGRESS IN THE TREATMENT OF VISCERAL AND RENAL ARTERY DISEASE
x
3:18 PM - 3:23 PM DEBATE: All Visceral And Renal Artery Aneurysms Can Be Treated Endovascularly
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
  View Slides in PDF      
3:24 PM - 3:29 PM DEBATE: Open Treatment Of Visceral And Renal Artery Aneurysms Is Sometimes Best: When Is This
  Presenter(s):Timur P. Sarac, MD  
  View Slides in PDF      
3:30 PM - 3:35 PM Technical Tips For Percutaneous Endovascular Treatment Of Visceral And Renal Artery Aneurysms
  Presenter(s):Jacob Cynamon, MD, FACR, FSIR  
  View Slides in PDF      
3:36 PM - 3:41 PM Update On New SVS Practice Guidelines For Treating Visceral Artery Aneurysms; When Endo; When Open
  Presenter(s):Rabih A. Chaer, MD  
  View Slides in PDF      
3:42 PM - 3:47 PM Current Optimal Treatment Of Pancreatico-Duodenal Aneurysms With And Without Celiac Axis Occlusion: When Endo; When Open: Why They Are Both Challenging
  Presenter(s):Benjamin M. Jackson, MD / Ronald M. Fairman, MD  
  View Slides in PDF      
3:48 PM - 3:53 PM At What Size Do Renal Artery Aneurysms Need To Be Treated Invasively: A New Vascular Consortium Study Shows They Are Only Dangerous When >3 cm In Diameter
  Presenter(s):Peter F. Lawrence, MD  
  View Slides in PDF      
3:54 PM - 3:59 PM Optimal Current Treatment Of Renal Artery Aneurysms: When Endo; When Open; Technical Tips
  Presenter(s):Fred A. Weaver, MD, MMM  
  View Slides in PDF      
4:00 PM - 4:06 PM Panel Discussion
END OF SESSION 19
 
SESSION 20 SCHEDULE
Tuesday
SESSION 20: UPDATE ON OPEN VASCULAR SURGICAL AND HYBRID PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS
x
OPEN AND HYBRID VASCULAR SURGERY
4:06 PM - 4:11 PM Minimal Incision For Retroperitoneal Aorto-Bifemoral Bypass: Technical Tips And Limitations
  Presenter(s):Robert M. Proczka, MD, PhD  
  View Slides in PDF      
4:12 PM - 4:17 PM Duplex Surveillance Should Be Used After All Aorto-Bifemoral Bypasses: It Improves Outcomes
  Presenter(s):Keith D. Calligaro, MD  
  View Slides in PDF      
4:18 PM - 4:23 PM Thoraco-Bifemoral Bypass: A Good Option After All Endo And Open Standard Approaches Have Failed: Technical Tips
  Presenter(s):Manju Kalra, MBBS  
  View Slides in PDF      
4:24 PM - 4:29 PM Long-Term Survival Results After Type II TAAA Endovascular Repair: When Is The Procedure Contraindicated
  Presenter(s):Matthew J. Eagleton, MD  
  View Slides in PDF      
4:30 PM - 4:35 PM Technical Tips For Aortic And Inferior Vena Cava Resections During Cancer Operations
  Presenter(s):Benjamin M. Jackson, MD  
  View Slides in PDF      
UPDATE ON COARCTATION TREATMENT
4:36 PM - 4:41 PM Endovascular Techniques Are The Best Treatment For Aortic Coarctations: When Bare Stents; When Covered Stents; Precautions
  Presenter(s):Zvonimir Krajcer, MD, FACC  
  View Slides in PDF      
4:42 PM - 4:47 PM

Power Point Presentation with Synched Audio
Value Of BeGraft (From Bentley), A Balloon Expandable Covered Stent In Treating Aortic Coarctations: Can It Treat All Cases
  Presenter(s):Elchanan Bruckheimer, MBBS  
  View Slides in PDF      
4:48 PM - 4:53 PM Long-Term Outcomes Of Stent-Graft Treatment Of Aortic Coarctations
  Presenter(s):Frank R. Arko, MD  
  View Slides in PDF      
4:54 PM - 5:00 PM Panel Discussion
END OF SESSION 20
 
SESSION 21 SCHEDULE
Tuesday
SESSION 21: ETHANOL ENDOVASCULAR CURATIVE TREATMENT OF VASCULAR MALFORMATIONS – PART 1
x
5:00 PM - 5:02 PM Welcome And Introduction
  Presenter(s):Krassi Ivancev, MD, PhD  
5:03 PM - 5:08 PM International Society for the Study of Vascular Anomalies (ISSVA) Classification System: How It Is Applied In My Practice
  Presenter(s):Wayne F. Yakes, MD  
  View Slides in PDF      
5:09 PM - 5:17 PM The Yakes AVM Classification System: A Guide For Curative AVM Treatment As Documented In 100 Consecutive AVM Patients
  Presenter(s):Krassi Ivancev, MD, PhD  
  View Slides in PDF      
5:18 PM - 5:26 PM A Step-By-Step Practicum For Ethanol Endovascular Treatment Of AVMs Applying The Yakes Classification System
  Presenter(s):Robert L. Vogelzang, MD  
  View Slides in PDF      
5:27 PM - 5:34 PM A Step-By-Step Practicum For Ethanol Endovascular Treatment Of Venous Malformations
  Presenter(s):Krassi Ivancev, MD, PhD  
  View Slides in PDF      
5:35 PM - 5:40 PM Panel Discussion
END OF SESSION 21
 
SESSION 22 SCHEDULE
Tuesday
SESSION 22: ETHANOL ENDOVASCULAR CURATIVE TREATMENT OF VASCULAR MALFORMATIONS – PART 2
x
5:41 PM - 5:48 PM Curative Ethanol Endovascular Treatment of Complex Head & Neck AVMs
  Presenter(s):Wayne F. Yakes, MD  
  View Slides in PDF      
5:49 PM - 5:55 PM New Agents And Drugs For Vascular Malformation Management: Do They Offer Any Hope
  Presenter(s):Robert L. Vogelzang, MD  
  View Slides in PDF      
5:56 PM - 6:03 PM Endovascular Ethanol Treatment Of Complex Low-Flow Venous And Lymphatic Malformations
  Presenter(s):Wayne F. Yakes, MD  
  View Slides in PDF      
6:04 PM - 6:10 PM Problems! I’ve Got ‘Em---Managing The Tough Vascular Malformation Case
  Presenter(s):Robert L. Vogelzang, MD  
  View Slides in PDF      
6:10 PM - 6:10 PM End of Program B
END OF SESSION 22
 
SESSION 23 SCHEDULE
Wednesday
SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI
x
6:40 AM - 6:45 AM Do Diabetic Patients With CLTI And Substantial Foot Necrosis Have Time For An Endovascular First Strategy: Why Primary Open Bypass Treatment Is Better
  Presenter(s):Katariina M. Noronen, MD, PhD  
  View Slides in PDF      
6:46 AM - 6:51 AM Key New Developments In Endovascular Treatments For CLTI
  Presenter(s):Sahil A. Parikh, MD  
  View Slides in PDF      
OPTIMAL TECHNIQUES FOR VESSEL PREP FOR ENDOVASCULAR TREATMENTS
6:52 AM - 6:57 AM Technical Tips For Vessel Prep Before DCBs And DESs: It Is Different And Not Simple
  Presenter(s):Erwin Blessing, MD  
  View Slides in PDF      
6:58 AM - 7:03 AM Thirteen Technical Tips For Safe Radial Access For Renal/Visceral And Lower Extremity Interventions: How Far Distally In The Leg Can Lesions Be Treated
  Presenter(s):Craig M. Walker, MD  
  View Slides in PDF      
7:04 AM - 7:09 AM What Are The Downsides To Trans-Radial Or Pedal Access
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
TECHNICAL TIPS ON GUIDEWIRE CHOICE AND USAGE
7:10 AM - 7:15 AM Tips For Treating Difficult BTK/BTA Lesions: How To Get A Guidewire Across A Long Calcified Occlusion And Getting A Resistant Balloon To Go Over The Wire
  Presenter(s):Marco G. Manzi, MD  
  View Slides in PDF      
7:16 AM - 7:22 AM Panel Discussion
END OF SESSION 23
 
SESSION 24 SCHEDULE
Wednesday
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
x
PROGRESS IN ATHERECTOMY
7:22 AM - 7:27 AM New Developments In Laser Atherectomy: What Makes It Different: When Is It Beneficial With Certainty
  Presenter(s):George L. Adams, MD, FACS  
  View Slides in PDF      
7:28 AM - 7:33 AM Value Of Phoenix Atherectomy And Stellarex DCB For Infrapopliteal Lesions: Why IVUS Guidance Is Beneficial: 1-Year Results In CLTI Patients
  Presenter(s):Michael K.W. Lichtenberg, MD / Thomas Zeller, MD  
  View Slides in PDF      
7:34 AM - 7:39 AM Optical Coherence Tomography (OCT) Guided Atherectomy (Pantheris) For In Stent Restenosis (ISR): Why It Is More Effective Treatment: From The INSIGHT Trial
  Presenter(s):Todd R. Vogel, MD, MPH  
  View Slides in PDF      
7:40 AM - 7:45 AM Current Role Of Atherectomy In Treating Lower Extremity CLTI: A Vascular Surgeon’s View
  Presenter(s):James F. McKinsey, MD  
  View Slides in PDF      
UPDATE ON THE SUPERA STENT
7:46 AM - 7:51 AM

Power Point Presentation with Synched Audio
Update On The Advantages Of The Supera Vasculomimetic (VMI) Stent For Treating Long Complex Fempop Occlusive Lesions: Is There Value To DCB Vessel Prep First
  Presenter(s):Peter C.J. Goverde, MD  
7:52 AM - 7:57 AM Value And Technical Tips To Make The Supera Stent Work In Curved And Angulated Non-SFA Lesion Locations
  Presenter(s):Rajiv Parakh, MBBS, MS, FRCS  
  View Slides in PDF      
DRUG ELUTING STENTS FOR BTK LESIONS
7:58 AM - 8:03 AM 10-Year Experience With Everolimus DESs To Treat Long Infrapopliteal Lesions Causing CLTI: Indications, Results, Value And Limitations
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
  View Slides in PDF      
8:04 AM - 8:09 AM What Is The Future For Bioresorbable DESs To Treat BTK Lesions: Good Long-Term Results Including The DISAPPEAR Trial Justify A New Trial: The LIFE-BTK Trial With The Esprit Stent From Abbott
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Sahil A. Parikh, MD / Brian G. DeRubertis, MD / Steven Kum, MD  
  View Slides in PDF      
8:10 AM - 8:15 AM A 3-French Compatible Microstent (From Micro Medical) For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: The STAND Trial
  Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI  
  View Slides in PDF      
8:16 AM - 8:22 AM Panel Discussion
END OF SESSION 24
 
SESSION 25 SCHEDULE
Wednesday
SESSION 25: LOWER EXTREMITY TOPICS RELATED TO THE DRUG COATED DEVICES CAUSING INCREASED MORTALITY CONTROVERSY: DO PACLITAXEL COATED DEVICES CAUSE INCREASED MORTALITY (5 AND 4 ¾-MINUTE SHORT SUMMARY [SS] TALKS)
x
8:22 AM - 8:27 AM Older And More Recent Meta-Analyses Reveal An Increased Mortality Signal In Patients Receiving Paclitaxel Coated Devices Compared To Uncoated Devices: A More Recent Study Reveals Increased Amputation Rates With Paclitaxel Coated Devices: What About Mortality
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
  View Slides in PDF      
8:28 AM - 8:33 AM Large Population Based German Multicenter Study Of Paclitaxel Coated BTK DCBs And DESs Indicates Decreased Mortality And Amputation Rates Compared To Uncoated Devices: Initial Thoughts About Katsanos’ Recent Amputation Data
  Presenter(s):Christian A. Behrendt, MD  
  View Slides in PDF      
8:34 AM - 8:39 AM Real World Big Data Patient-Level Evidence Confirms No Harm From Paclitaxel Coated Devices For Treating Fempop Disease: Update On Medicare Data From Over 150,000 Patients
  Presenter(s):Eric A. Secemsky, MD, MSc / Robert Yeh, MD  
  View Slides in PDF      
8:40 AM - 8:45 AM Mortality Rates After Paclitaxel Coated Device Use In Patients With Both Critical Limb Ischemia (CLI) And Claudication: Two Systematic Reviews And Meta-Analyses Of Randomized Controlled Trials Show NO Increased Mortality With Paclitaxel Coated Devices Up To 5 Years
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Andrew Holden, MBChB / Krystal Dinh, MD / Peter A. Schneider, MD  
  View Slides in PDF      
RELEVANT COMMENTS AS SHORT SUMMARY [SS] TOPICS (4 ¾-MINUTE TALKS)
8:46 AM - 8:51 AM [SS] The Paclitaxel Increased Mortality Effect Reported By Dr. Katsanos et al. Seems Not To Be Confirmed By Added Data: Initial Thought About Katsanos’ Recent Meta-Analysis Showing Increased Amputation Rates With Paclitaxel Coated Devices
  Presenter(s):Peter A. Schneider, MD  
  View Slides in PDF      
8:51 AM - 8:56 AM [SS] New Data On The Paclitaxel Mortality Controversy: Should You Continue Using These Devices
  Presenter(s):Gary M. Ansel, MD  
  View Slides in PDF      
8:56 AM - 9:01 AM [SS] VQI Data Do Not Support The Paclitaxel Increased Mortality Signal
  Presenter(s):Daniel J. Bertges, MD / Jack L. Cronenwett, MD  
  View Slides in PDF      
9:01 AM - 9:08 AM Panel Discussion
END OF SESSION 25
 
SESSION 26 SCHEDULE
Wednesday
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs (5-MINUTE TALKS)
x
NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs
9:08 AM - 9:13 AM

Power Point Presentation with Synched Audio
Cost Effectiveness Of Drug Eluting Technologies For Femoropopliteal Lesions: They Are Worth The Increased Device Costs
  Presenter(s):Stefan Mueller-Huelsbeck, MD  
  View Slides in PDF      
9:14 AM - 9:19 AM Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Effective In Fempop Lesions: Final 5-Year Data From The ILLUMENATE RCTs
  Presenter(s):Sean P. Lyden, MD  
  View Slides in PDF      
9:20 AM - 9:25 AM Pooled Data From The In.Pact RCT DCB Trials For SFA-Pop Lesions Show Safety And Efficacy For 5 Years Compared To POBA: Continued Use Is Justified
  Presenter(s):Peter A. Schneider, MD / John R. Laird, MD  
  View Slides in PDF      
9:26 AM - 9:31 AM New Findings From The DRASTICO Study Comparing DESs To DCBs For Fempop Lesions: 4-Year Results With TASC A/B Lesions Versus TASC C/D Lesions
  Presenter(s):Francesco Liistro, MD  
  View Slides in PDF      
9:32 AM - 9:37 AM

Power Point Presentation with Synched Audio
Update On The Randomized Head To Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 2-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages
  Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD  
  View Slides in PDF      
9:38 AM - 9:43 AM Update On The Global RANGER II RCT Comparing Ranger DCBs With POBA
  Presenter(s):Marianne Brodmann, MD  
  View Slides in PDF      
9:44 AM - 9:49 AM Panel Discussion
9:49 AM - 10:02 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
Session 26 will continue after the Break.
NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs (5-MINUTE TALKS)
Moderator(s): Joseph L. Mills, MD / John R. Laird, MD  
10:02 AM - 10:07 AM

Power Point Presentation with Synched Audio
New Information On The Safety And Effectiveness Of The Cook Zilver PTX DES Based On Global Trials Including A RCT: When Is It The Best Treatment
  Presenter(s):Michael D. Dake, MD  
  View Slides in PDF      
10:08 AM - 10:13 AM Update On Clinical Trials Of The Boston Scientific Eluvia DES
  Presenter(s):William A. Gray, MD / Stefan Mueller-Huelsbeck, MD / Thomas Zeller, MD  
  View Slides in PDF      
NEW INFORMATION ON BTK DCBs AND DESs
10:14 AM - 10:19 AM The Sirolimus DCB BTK Era Begins – Current Experience With The Selution DCB And Design Of The SELUTION SLR .014 BTK IDE Trial: Early Results From Singapore And Europe
  Presenter(s):Patrick J. Geraghty, MD  
  View Slides in PDF      
10:20 AM - 10:25 AM 1-Year Results From The AcoArt II BTK DCB RCT Show Safety (No Increased Mortality) And Improved Patency Versus POBA
  Presenter(s):Francesco Liistro, MD / Wei Guo, MD  
  View Slides in PDF      
10:26 AM - 10:31 AM Why BTK DCB Trials Do Not Show Uniformly Better Results: Technical Factors Matter
  Presenter(s):Francesco Liistro, MD / Wei Guo, MD  
  View Slides in PDF      
10:32 AM - 10:37 AM Update On The SAVAL Trial With A Self-Expanding DES (From Boston Scientific) For BTK Occlusive Lesions
  Presenter(s):Jihad A. Mustapha, MD / Miguel F. Montero-Baker , MD  
  View Slides in PDF      
10:38 AM - 10:43 AM Panel Discussion
END OF SESSION 26
 
SESSION 27 SCHEDULE
Wednesday
SESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: HOW TO SAVE THE “NO OPTION FOR TREATMENT” LIMB OR THE “DESERT FOOT” WITH NO PATENT TARGET ARTERIES
x
10:43 AM - 10:48 AM Contemporary Survival After Below-Knee Amputation (BKA), Above-Knee Amputation (AKA), Bilateral Amputations For Trauma; For Vascular Disease: It Is Worthwhile Saving Limbs Especially In Vascular Patients
  Presenter(s):Philip P. Goodney, MD, MS  
  View Slides in PDF      
VALUE OF PROSTHETIC (PTFE) TIBIAL BYPASSES
10:49 AM - 10:54 AM Value Of Spliced Vein Grafts Versus PTFE Grafts For Bypasses: When A Single Autologous Vein Is Inadequate
  Presenter(s):Joseph L. Mills, MD  
  View Slides in PDF      
10:55 AM - 11:00 AM PTFE Tibial And Peroneal Artery Bypasses Can Save No Option Limbs Which Would Otherwise Require Amputation: They Can Have Long-Term Patency And Limb Salvage And Are Worthwhile
  Presenter(s):Gregg S. Landis, MD / Richard F. Neville, MD / Hasan H. Dosluoglu, MD / Neal S. Cayne, MD / Mark A. Adelman, MD / Frank J. Veith, MD  
  View Slides in PDF      
11:01 AM - 11:06 AM For Patients Facing Amputation With No Endo Options Or Useable Vein, PTFE Tibial Bypasses Are A Worthwhile Option
  Presenter(s):R. Clement Darling III, MD  
  View Slides in PDF      
11:07 AM - 11:12 AM Current Outcomes With PTFE Bypasses To Infrapopliteal (Tibial) Targets: Is There Variability Between Surgeons And Institutions
  Presenter(s):Matthew T. Menard, MD  
  View Slides in PDF      
11:13 AM - 11:18 AM Panel Discussion
UPDATE ON FOOT VEIN ARTERIALIZATION FOR CLTI
11:18 AM - 11:23 AM What Is The Real Prevalence Of No Option Anatomy Among The CLTI Population: What Is The Role For Foot Vein Arterialization: Impact Of The PROMISE I Trial With The LimFlow System
  Presenter(s):Peter A. Schneider, MD  
  View Slides in PDF      
11:24 AM - 11:29 AM

Power Point Presentation with Synched Audio
Role And Value Of Vein Arterialization: Best Way To Do It And Long-Term Results: From The Pioneer
  Presenter(s):Pramook Mutirangura, FRCS (Edinburgh)  
  View Slides in PDF      
11:30 AM - 11:35 AM

Power Point Presentation with Synched Audio
Pathophysiology Of Venous Arterialization And Neo Angiogenesis For No Option CLTI: How To Predict When It Will Work And When It Won’t
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
11:36 AM - 11:41 AM 2-Year Registry Results With Deep Vein Arterialization With The LimFlow Device For CLTI With Gangrene Shows Reasonable Limb Salvage And Wound Healing
  Presenter(s):Daniela Branzan, MD / Andrej Schmidt, MD  
  View Slides in PDF      
11:42 AM - 11:47 AM How To Perform The LimFlow Procedure: Equipment Required And Technical Tips
  Presenter(s):Miguel F. Montero-Baker , MD  
  View Slides in PDF      
11:48 AM - 11:53 AM Deep Vein Arterialization And Valve Lysis By Surgical Means For No Option Desert Feet With Gangrene: How To Do It And Results
  Presenter(s):Richard F. Neville, MD  
  View Slides in PDF      
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 27
 
SESSION 28 SCHEDULE
Wednesday
SESSION 28: NEW DEVELOPMENTS IN STENTS; PROSTHETIC GRAFTS; ENDOVASCULAR BYPASSES; STENT GRAFTS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
x
1:00 PM - 1:04 PM 3-Year Results From The BioMimics 3D Swirling Flow Stent In The MIMICS-2 Study: Who Needs Paclitaxel
  Presenter(s):Michael K.W. Lichtenberg, MD / Peter Gaines, MD / Timothy M. Sullivan, MD  
  View Slides in PDF      
ARTERIAL PTFE BYPASSES
1:06 PM - 1:11 PM

Power Point Presentation with Synched Audio
RCT Comparing Heparin Bonded PTFE (Propaten) Grafts With Plain PTFE Grafts For BTK CLTI Bypasses: Is Heparin Bonding Helpful
  Presenter(s):Yann Gouëffic, MD, PhD  
  View Slides in PDF      
1:12 PM - 1:17 PM Hybrid Fluoroscopically Guided Improved Method For Restoring Patency To Occluded PTFE Bypasses: It’s Less Invasive And More Effective
  Presenter(s):Neal S. Cayne, MD / Frank J. Veith, MD  
  View Slides in PDF      
PERCUTANEOUS BYPASSES
1:18 PM - 1:23 PM Percutaneous (PQ) Tranvenous Fempop PTFE Bypasses With The Torus 2 Device: How It Works And Status Of The DETOUR And TORUS Trials In The US And Europe
  Presenter(s):Sean P. Lyden, MD / Daniel G. Clair, MD / Ehrin Armstrong, MD / Peter A. Schneider, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM 3-Year Results Of The Detour PQ Fempop Arterial Bypass Routed Through TheFemoral Vein: Will It Make Open Bypass Obsolete
  Presenter(s):Dainis K. Krievins, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM A Novel Technique For PQ Fempop Bypass Routing The PTFE Bypass Through The Soft Tissue Of The Thigh: How To Do It And Early Results
  Presenter(s):Pierre G. Sarradon, MD / Jean-Pierre Becquemin, MD, FRCS  
  View Slides in PDF      
NEW INFORMATION ON STENT-GRAFTS
1:36 PM - 1:41 PM 2-Year Results Of The SUPER B RCT Shows That Viabahn Stent-Grafts Have Patency Rates As Good As Open Fempop PTFE Bypasses But Require More Reinterventions: How To Make Viabahns Work Best
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
TREATMENT OF IN STENT RESTENOSIS (ISR)
1:42 PM - 1:47 PM Laser Atherectomy May Facilitate Endovascular Treatment Of ISR But Does Not Provide Long-Term Benefit: How Should ISR Be Treated
  Presenter(s):Russell H. Samson, MD, DFSVS, RVT, FACS  
  View Slides in PDF      
1:48 PM - 1:53 PM The Excimer Laser For Treating ISR: It Has A Role In Grossing And Debulking Difficult Lesions: Technical Tips
  Presenter(s):Craig M. Walker, MD  
  View Slides in PDF      
1:54 PM - 2:00 PM Panel Discussion
END OF SESSION 28
 
SESSION 29 SCHEDULE
Wednesday
SESSION 29: LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
x
2:00 PM - 2:05 PM Update On The BEST-CLI RCT Comparing Endovascular And Open Treatment Of Lower Extremity Ischemia: Current Status, Challenges And What Will Be Its Value
  Presenter(s):Matthew T. Menard, MD / Alik Farber, MD, MBA / Kenneth Rosenfield, MD  
  View Slides in PDF      
METHODS FOR EVALUATING FOOT PERFUSION
2:06 PM - 2:11 PM

Power Point Presentation with Synched Audio
Measuring Foot Perfusion After Endo Treatments For CLTI With Perfusion Angiography And Smart Software: Why It Is Important And How To Do It
  Presenter(s):Jim Reekers, MD, PhD  
  View Slides in PDF      
2:12 PM - 2:17 PM Indocyanine Green Fluorescence (IGC-FL) Is A Good Way To Measure Foot Perfusion After Treatment: How It Explains Why The Angiosome Concept Is Important After Endo Treatments But Not After Bypasses
  Presenter(s):Maarit Venermo, MD, PhD  
  View Slides in PDF      
2:18 PM - 2:23 PM How And Why To Measure Foot Perfusion During Endo Treatments: Hyperspectral Imaging, O2 Sensors, Etc: When Is The Angiosome Concept Helpful; When Not
  Presenter(s):Marianne Brodmann, MD  
  View Slides in PDF      
2:24 PM - 2:29 PM What Are The Best Ways To Evaluate CLTI Treatment Outcomes: Physiology, Wound Healing, Anatomy (Angiography Or Ultrasound), MACE Or MALE: Why It Matters
  Presenter(s):Ido Weinberg, MD, MSc  
  View Slides in PDF      
2:30 PM - 2:35 PM Pedal Arch Patency Is Key To Predicting Limb Salvage With Endovascular Treatment For CLTI With Tissue Necrosis: How Is It Best Evaluated
  Presenter(s):Hasan H. Dosluoglu, MD / Linda Harris, MD  
  View Slides in PDF      
2:36 PM - 2:41 PM Foot Perfusion Measurements Show Why Open Bypasses Are Better Than Endovascular Treatments For CLTI
  Presenter(s):Werner Lang, MD  
  View Slides in PDF      
2:42 PM - 2:48 PM Panel Discussion
2:48 PM - 3:08 PM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 29
 
SESSION 30 SCHEDULE
Wednesday
SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION AND ACUTE LIMB ISCHEMIA
x
INTERMITTENT CLAUDICATION (IC)
3:08 PM - 3:13 PM Overuse Of Vascular Interventions For IC Is A Measure Of Poor Care: How Is This Determined
  Presenter(s):Caitlin W. Hicks, MD, MS / James H. Black, III, MD  
  View Slides in PDF      
ACUTE LIMB ISCHEMIA (ALI) (See Also Session 59)
3:14 PM - 3:19 PM Update On Thrombosuction Devices For Treating ALI: Which Device In Which Circumstance: Advantages And Limitations
  Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD  
  View Slides in PDF      
3:20 PM - 3:25 PM Computer Aided Mechanical Aspiration Thrombectomy (CMAT) Is Obviating The Need For Thrombolytics In ALI: Which Device Is Best When And Why
  Presenter(s):Patrick E. Muck, MD, FACS  
  View Slides in PDF      
3:26 PM - 3:31 PM Aspiration Thrombectomy Devices And Techniques For ALI: Are Thrombolytics And Fogarty Balloon Catheters Obsolete
  Presenter(s):Maria A. Ruffino, MD, EBIR  
  View Slides in PDF      
3:32 PM - 3:37 PM Penumbra Indigo Clot Aspiration System To Treat ALI: Why Is It A Game Changer: Technical Tips For Usage
  Presenter(s):James F. Benenati, MD  
  View Slides in PDF      
3:38 PM - 3:43 PM Value And Technical Tips For Using The Indigo Clot Removal System Before Treating ISR And Other Lesions With Balloon And Stents
  Presenter(s):Frank R. Arko, MD  
  View Slides in PDF      
3:44 PM - 3:49 PM How To Treat ALI Under Duplex Ultrasound Guidance: Advantages And Limitations
  Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM / Enrico Ascher, MD  
  View Slides in PDF      
3:50 PM - 3:56 AM Panel Discussion
END OF SESSION 30
 
SESSION 31 SCHEDULE
Wednesday
SESSION 31: ADVANCES IN MEDICAL TREATMENTS, NEW ANTIATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
x
3:56 PM - 4:01 PM What Adequate And Ideal Lipid Levels Should We Strive For In PAD Patients: How To Get There
  Presenter(s):Marianne Brodmann, MD  
  View Slides in PDF      
4:02 PM - 4:07 PM Risks And Consequences Of Perioperative Myocardial Infarctions (MIs) In Open Vascular Surgery Patients: What Can Be Done To Decrease MI Incidence And Their Morbidity And Mortality When They Occur
  Presenter(s):Peter Henke, MD  
  View Slides in PDF      
4:08 PM - 4:13 PM

Power Point Presentation with Synched Audio
Update On LDL-C Lowering During A Lifetime: How Low To Strive For; How Young To Start If High; How Old To Continue Statins
  Presenter(s):J. David Spence, MD  
  View Slides in PDF      
4:14 PM - 4:19 PM DEBATE: LDL-C Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS  
  View Slides in PDF      
4:20 PM - 4:25 PM DEBATE: Not So: LDL-C Lowering With Statins And Other Drugs Stabilizes And Shrinks Plaques And Decreases Morbid Vascular Events: Stopping Statins Increases Patients’ Risk Of MI And Death
  Presenter(s):Ron Waksman, MD  
  View Slides in PDF      
4:26 PM - 4:31 PM Low Dose Rivaroxaban And Aspirin Improve Survival And Decrease Major Adverse Limb Events (MALE) After Endo And Open Treatments For PAD/CLTI: From The VOYAGER RCT
  Presenter(s):Sebastian E. Debus, MD, PhD / Marianne Brodmann, MD  
  View Slides in PDF      
4:32 PM - 4:37 PM How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And COMPASS Trials
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Slides in PDF      
4:38 PM - 4:43 PM New Adjunctive Drugs (Plus Statins) To Lower LDL-Cholesterol (LDL-C) In Vascular Patients: Inclisiran, Bempedoic Acid And Ezetimbe: How Do They Work And When And How To Use Them: Level Of LDL-C To Strive For
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
  View Slides in PDF      
4:44 PM - 4:50 PM Panel Discussion
END OF SESSION 31
 
SESSION 32 SCHEDULE
Wednesday
SESSION 32: CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; VASCULAR AND CARDIAC COMPLICATIONS OF COVID-19
x
UPDATE ON RENAL DENERVATION FOR HYPERTENSION
4:50 PM - 4:55 PM Current Status Of Renal Denervation For Drug Resistant Hypertension: Why The Simplicity Spyral Radiofrequency Denervation System Is Different: Status Of The SPYRAL HTN-OFF MED RCT (Versus Sham)
  Presenter(s):Sahil A. Parikh, MD  
  View Slides in PDF      
4:56 PM - 5:01 PM Preop Cardiac Evaluation With CT-Based Fractional Flow Reserve (FFRCT) And Selective Coronary Revascularization Saves Lives In Patients Undergoing Procedures For CLTI And Carotid Disease
  Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD  
  View Slides in PDF      
5:02 PM - 5:07 PM

Power Point Presentation with Synched Audio
How And Why Do Thoracic Stent-Grafts For TEVAR Negatively Affect The Heart
  Presenter(s):Frans L. Moll, MD, PhD  
  View Slides in PDF      
5:08 PM - 5:13 PM Permissive Transfusion Strategies Increase Mortality And Serious Adverse Events After Major Vascular And General Surgery Operative Interventions
  Presenter(s):Panos Kougias, MD, MSc  
  View Slides in PDF      
5:14 PM - 5:19 PM Vascular Complications Of COVID-19 Infections: What Is Known And Unknown: How To Diagnose And Treat
  Presenter(s):Michael E. Barfield, MD  
  View Slides in PDF      
5:20 PM - 5:25 PM

Power Point Presentation with Synched Audio
Cardiac Complications Of COVID-19 Infections: What Is Their Genesis: Diagnosis And Treatment
  Presenter(s):Roxana Mehran, MD  
  View Slides in PDF      
5:26 PM - 5:31 PM Panel Discussion
5:31 PM - 5:31 PM End of Program C
END OF SESSION 32
 
SESSION 33 SCHEDULE
Wednesday
SESSION 33: PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
x
TO TREAT OR NOT TO TREAT TYPE 2 ENDOLEAKS
7:00 AM - 7:05 AM Most Type 2 Endoleaks Are Benign: The Case Can Be Made That By Treating Type 2 Endoleaks The Harm And Cost Of Such Treatment Outweighs The Benefits: When If Ever Should They Be Treated; AAA Sac Behavior Predicts Late Survival After EVAR
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
TREATING TYPE 1 ENDOLEAKS
7:06 AM - 7:11 AM Type 1A Endoleaks After EVAR Are Predictable And Preventable: How To Do So
  Presenter(s):Michael J. Singh, MD  
  View Slides in PDF      
7:12 AM - 7:17 AM When And How To Use Embolization Coils To Treat Type 1A Endoleaks Successfully: When Won’t Coils Work: How To Diagnose Type 1A Endoleaks Accurately
  Presenter(s):Sigrid Nikol, MD  
  View Slides in PDF      
7:18 AM - 7:23 AM

Power Point Presentation with Synched Audio
How To Minimize Gutter Type 1A Endoleaks With Chimney EVAR (Ch/EVAR): How To Treat Them When They Occur: When Not To Treat Them
  Presenter(s):Konstantinos P. Donas, MD  
  View Slides in PDF      
7:24 AM - 7:29 AM

Power Point Presentation with Synched Audio
Shape Memory Technology For AAA Sac Filling: How Does It Work And Why It May Be A Better Form Of EVAR
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
ROLE OF INFLAMMATION
7:30 AM - 7:35 AM The Role Of Inflammation In Causing Late Endoleaks: How To Evaluate It And How Should It Influence Treatment
  Presenter(s):Furuzan Numan, MD  
  View Slides in PDF      
7:36 AM - 7:42 AM Panel Discussion
END OF SESSION 33
 
SESSION 34 SCHEDULE
Wednesday
SESSION 34: PREVENTION OF TYPE 2 ENDOLEAKS AFTER EVAR
Moderators:Ross Milner, MD / Adam Beck, MD  
x
7:42 AM - 7:47 AM

Power Point Presentation with Synched Audio
A RCT Shows The Advantages Of Inferior Mesenteric Artery (IMA) And Lumbar Embolization: Confirmed By A Japanese RCT: When And How To Do It
  Presenter(s):Dominique Fabre, MD, PhD / Stephan Haulon, MD  
  View Slides in PDF      
7:48 AM - 7:53 AM With A Large IMA (> 3mm), When Should It Be Embolized; When Should It Be Revascularized And Why
  Presenter(s):Piotr M. Kasprzak, MD  
  View Slides in PDF      
TREATMENT OF TYPE 2 ENDOLEAKS AFTER EVAR
7:54 AM - 7:59 AM How Duplex Ultrasound Velocities In Type 2 Endoleaks Determine Behavior And Help In Treatment: Technical Tips
  Presenter(s):Ross Milner, MD  
  View Slides in PDF      
8:00 AM - 8:05 AM Glue Embolization Is Effective Treatment For Most Threatening Type 2 Endoleaks: When And How Best To Do It
  Presenter(s):Neal S. Cayne, MD  
  View Slides in PDF      
8:06 AM - 8:11 AM Transcaval Access To AAA Sacs For Treatment Of Type 2 Endoleaks After EVAR: When And How To Do It
  Presenter(s):Adam Beck, MD  
  View Slides in PDF      
8:12 AM - 8:17 AM How To Best Leverage 3D Fusion Software (GE) To Get Into The Nidus And Treat Type 2 Endoleaks: Best Embolic Agent And Value Of Transcaval Access
  Presenter(s):Mark W. Mewissen, MD, RVT  
  View Slides in PDF      
8:18 AM - 8:23 AM Transgraft Approach To Treat Type 2 Endoleaks: Indications, Equipment, Advantages And Precautions
  Presenter(s):James F. McKinsey, MD  
  View Slides in PDF      
8:24 AM - 8:29 AM Laser Assisted Transgraft Onyx Embolization Of Type 2 Endoleaks: Indications, Equipment And Technique
  Presenter(s):Zvonimir Krajcer, MD, FACC  
  View Slides in PDF      
8:30 AM - 8:35 AM With Type 2 Endoleaks And Sac Expansion Open Sacotomy And Branch Ligation Is The Best Treatment: Why And What Precautions Are Needed To Be Sure There Is Not Occult Type 1 Leak
  Presenter(s):Zachary M. Arthurs, MD  
  View Slides in PDF      
8:36 AM - 8:48 AM Panel Discussion
END OF SESSION 34
 
SESSION 35 SCHEDULE
Wednesday
SESSION 35: MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs) AND THEIR TREATMENT
x
8:48 AM - 8:53 AM False Lumen Area >50% Of Total Aortic Cross-Section Area At The Tracheal Bifurcation At Time Of TEVAR For TBAD Is A Predictor Of Early Death: How To Decrease This Mortality
  Presenter(s):Johnny Steuer, MD, PhD  
  View Slides in PDF      
8:54 AM - 8:59 AM Results From A Global Multicenter Registry On Candy Plug In Chronic TBAD
  Presenter(s):Tilo Koelbel, MD, PhD  
  View Slides in PDF      
9:00 AM - 9:05 AM Staged Hybrid Single Lumen Reconstruction Is The Best Treatment For Complex Chronic TBAD With Visceral Segment Involvement Of The Aorta: How To Do It, Advantages And Results
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS  
  View Slides in PDF      
9:06 AM - 9:11 AM Reinterventions After TEVAR For TBADs: How To Decrease Them At The Index Procedure And How Planning Helps
  Presenter(s):Bijan Modarai, PhD, FRCS  
  View Slides in PDF      
9:12 AM - 9:17 AM Adjunctive Peripheral And Visceral Interventions During TEVAR For Complicated TBADs: Indications, Technical Tips And Results
  Presenter(s):Mark K. Eskandari, MD  
  View Slides in PDF      
9:18 AM - 9:23 AM Update On Intramural Hematoma (IMH): Etiology, Natural History And Indications For TEVAR
  Presenter(s):Frank J. Criado, MD  
  View Slides in PDF      
9:24 AM - 9:30 AM Panel Discussion
9:30 AM - 9:42 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 35
 
SESSION 36 SCHEDULE
Wednesday
SESSION 36: MORE ADVANCES RELATED TO LESIONS INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS AND THEIR TREATMENT
x
9:42 AM - 9:47 AM Value Of Transcranial Doppler (TCD) For TEVAR And Endo Procedures Involving The Ascending Aorta And Aortic Arch
  Presenter(s):Alan B. Lumsden, MD, FACS  
  View Slides in PDF      
9:48 AM - 9:53 AM Antegrade Stent-Graft Delivery For Treating Acute Type A Dissections: When Is It Advantageous And How To Do It
  Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD  
  View Slides in PDF      
9:54 AM - 9:59 AM The Pulley Effect: Endovascular Instrumentation At The Aortic Bifurcation Generates Unexpected Forces That May Tear The Aorta
  Presenter(s):Martin Malina, MD, PhD  
  View Slides in PDF      
10:00 AM - 10:05 AM For Precise TEVAR In The Aortic Arch Rapid Pacing And Caval Occlusion Are NOT Needed: Valsalva And PEEP By Anesthesiologist Do Just As Well And Are Simple: Technical Tips
  Presenter(s):Nikolaos Tsilimparis, MD, PhD  
  View Slides in PDF      
10:06 AM - 10:11 AM Arch Lesion Repair With Single, Double Or 3-Branched Devices: When Is Each Best And Why
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
10:12 AM - 10:17 AM Laser Fenestration Option For TEVAR Involving The Great Arch Branches: When Is It Better Than Branched Endografts: Technique And Results
  Presenter(s):Timothy A. Resch, MD, PhD  
  View Slides in PDF      
10:18 AM - 10:26 AM Panel Discussion
END OF SESSION 36
 
SESSION 37 SCHEDULE
Wednesday
SESSION 37: OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; NEW DEVICES FOR THEIR TREATMENT
x
COMPLEX AAAs AND TAAAs
10:27 AM - 10:32 AM Open Repair Is The Best Way To Treat Short Neck, No Neck And Pararenal AAAs: Why Is This So
  Presenter(s):Laurent Chiche, MD, FEBVS  
  View Slides in PDF      
10:33 AM - 10:38 AM Comparative Morbidity And Mortality Outcomes Of Open, Hybrid And F/B/EVAR For Type II And III TAAAs Justify Greater Use Of F/B/EVAR For These Complex Lesions
  Presenter(s):Gilbert R. Upchurch, MD / Salvatore T. Scali, MD / Dean Arnaoutakis, MD  
  View Slides in PDF      
10:39 AM - 10:44 AM New Techniques To Improve The Open Repair Of TAAAs
  Presenter(s):Laurent Chiche, MD, FEBVS  
  View Slides in PDF      
TOPICS RELATED TO INTERESTING NEW DEVICES
10:45 AM - 10:50 AM A New Hybrid Device (Thoracoflo From Terumo Aortic) For TAAA Repair: How It Works, Early Clinical Experience And Advantages
  Presenter(s):Sebastian E. Debus, MD, PhD  
  View Slides in PDF      
10:51 AM - 10:56 AM How To Prevent Patch Aneurysms After Open TAAA Repair With Long Antegrade Grafts: How To Treat Them When They Occur
  Presenter(s):Thomas C. Bower, MD / Manju Kalra, MBBS  
  View Slides in PDF      
10:57 AM - 11:02 AM Role Of Device Engineering On Sac Regression Seen With The TREO Endograft
  Presenter(s):Michael C. Stoner, MD  
  View Slides in PDF      
11:03 AM - 11:08 AM Update On The Colt Manifold Device For TAAAs, Complex AAAs, Failed EVARs And Failed EVAS Procedures: How Does It Work And Results
  Presenter(s):Piotr Szopinski, MD, PhD  
  View Slides in PDF      
11:09 AM - 11:17 AM Panel Discussion
END OF SESSION 37
 
SESSION 38 SCHEDULE
Wednesday
SESSION 38: PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS
x
TREATMENT OF ILIAC ANEURYSMS AND IBDs
11:18 AM - 11:23 AM

Power Point Presentation with Synched Audio
DEBATE: How Best To Treat Iliac Aneurysms In 2021: There Is Not Much Of A Need For Open Surgery
  Presenter(s):Stefan Mueller-Huelsbeck, MD  
  View Slides in PDF      
11:24 AM - 11:29 AM DEBATE: There Is A Role For Open Surgery In The Treatment Of Iliac Aneurysms: What Is It And Technical Tips
  Presenter(s):Heron E. Rodriguez, MD  
  View Slides in PDF      
11:30 AM - 11:35 AM Long-Term Experience With Cook IBD For The Treatment Of Common Iliac Aneurysms: Advantages And Limitations
  Presenter(s):Giovanni B. Torsello, MD  
  View Slides in PDF      
11:36 AM - 11:41 AM Update On The Gore IBE Excluder For Treating Iliac Aneurysms And Preserving Hypogastric Artery Flow: Advantages And Limitations: From The European ICEBERG Registry
  Presenter(s):Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
11:42 AM - 11:47 AM Advantages And Limitations Of The Jotec-Cryolite Iliac Branch Device For Treating Common And Internal Iliac Artery Aneurysms
  Presenter(s):Lee Bouwman, MD, PhD, MSc  
  View Slides in PDF      
11:48 AM - 11:53 AM MLFM Bare Stent (From Cardiatis) Is A Promising Treatment For Acute Aortic Dissections: What Is The Evidence In Support
  Presenter(s):Rodney A. White, MD  
  View Slides in PDF      
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 38
 
SESSION 39 SCHEDULE
Wednesday
SESSION 39: MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; LINK TO CANCER; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
x
1:00 PM - 1:05 PM A Novel New Technology (Nectero) To Slow AAA Growth; How Does It Work And Early Clinical Results
  Presenter(s):Venkatesh G. Ramaiah, MD  
  View Slides in PDF      
AAA NECK BEHAVIOR AFTER EVAR
1:06 PM - 1:11 PM Impact Of Oversizing And Level Of Fixation (Infra Versus Supra-Renal) On Aortic Neck Behavior: How Do These Variables Affect EVAR Outcomes: From A 10-Year Study
  Presenter(s):Carlos F. Bechara, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM Aortic Neck Dilatation Is Different After F/EVAR And EVAR: What Is The Reason And Why Is It Important For Outcomes
  Presenter(s):Thomas S. Maldonado, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM Major Aortic Neck Dilatation Occurs Equally After EVAR And Open Repair: From The DREAM RCT: This ONLY Occurs After EVAR With Self-Expanding Endografts
  Presenter(s):Jan D. Blankensteijn, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM Do AAA Necks Dilate After F/EVAR For Juxtarenal AAAs: What Are The Good Or Bad Consequences For Procedural Outcomes
  Presenter(s):Benjamin W. Starnes, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM DEBATE: Low Profile Devices For EVAR Are Failing: Their Future Is Questionable
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
1:36 PM - 1:41 PM DEBATE: Not So: Ovation Stent-Graft (From Endologix) Have Good 5-Year Results With No Neck Dilatation Or Migration Even With Challenging Neck Anatomy: Based On A Multicenter International Study Of A Low Profile Endograft
  Presenter(s):Mahmoud B. Malas, MD, MHS  
  View Slides in PDF      
1:42 PM - 1:47 PM Current Status Of The Link Between EVAR And Cancer: Is It Real And What Is Its Etiology
  Presenter(s):Janet T. Powell, MD, PhD  
  View Slides in PDF      
1:48 PM - 1:53 PM Presenting AAAs As Ticking Time Bombs Or Unexploded Grenades Is Wrong-Headed, Inaccurate And Harmful
  Presenter(s):Frank J. Criado, MD  
  View Slides in PDF      
1:54 PM - 2:00 PM Panel Discussion
END OF SESSION 39
 
SESSION 40 SCHEDULE
Wednesday
SESSION 40: MORE NEW DEVELOPMENTS IN AAAs: HOW DO THEIR NECK AND SAC SIZE AND THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR AND EVAS; OTHER RELATED AAA TOPICS
x
AAA NECK AND SAC THROMBUS LOAD
2:00 PM - 2:05 PM DEBATE: Large Amount Of AAA Sac Thrombus Promotes Morbidity With And Without Rupture: What Is The Mechanism And How To Quantitate Thrombus Load
  Presenter(s):David H. Deaton, MD, FACS  
  View Slides in PDF      
2:06 PM - 2:11 PM DEBATE: Large Flow Lumenal Space In AAA Sac With Minimal Mural Thrombus Is Associated With Adverse Events After EVAR: It Is More Important Than AAA Sac Size: Thrombus May Be Protective
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
2:12 PM - 2:17 PM Graft Infolding: A Unique EVAR Complication: How To Prevent It And How To Treat It
  Presenter(s):Ashraf Mansour, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM Large AAA Necks (> 29 mm) Increase Migration And Leak Risks After EVAR With Self-Expanding Endografts Due To Neck Dilatation: Not So With Anatomically Adaptive (Polymer) Sealing Endografts (Ovation) Which Are Not Followed With Neck Dilatation
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
2:24 PM - 2:29 PM Does Doxycycline Stabilize AAA Neck Diameter: From The NTACT Trial
  Presenter(s):Jon S. Matsumura, MD  
  View Slides in PDF      
2:30 PM - 2:35 PM EVAS With Sac Filling Technology (Nellix) Has Lower Late Mortality Than EVAR With Other Endografts – Especially With Large AAAs: What Is The Mechanism Thought To Be
  Presenter(s):Marc L. Schermerhorn, MD  
  View Slides in PDF      
2:36 PM - 2:42 PM Panel Discussion
2:42 PM - 2:56 PM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 40
 
SESSION 41 SCHEDULE
Wednesday
SESSION 41: HOT AORTIC TOPICS (4 ¾ AND 5--MINUTE FAST PACED TALKS)
x
2:56 PM - 3:01 PM A Large Proportion Of EVARs Are Performed On Small AAAs: What Are The Implications And What Should Be Done About It
  Presenter(s):Salvatore T. Scali, MD  
  View Slides in PDF      
3:01 PM - 3:06 PM Late Delayed Renal Artery Revascularization After Inadvertent Occlusion During Complex EVAR Is Worthwhile: Collaterals Keep The Kidney Viable Although No Urine Is Produced
  Presenter(s):Nikolaos Tsilimparis, MD, PhD  
  View Slides in PDF      
3:06 PM - 3:11 PM How Can A Long-Term Aortic Risk (LEAR) Model Predict Mortality And Complication Risks And Guide Surveillance: Can The Model Be Made Device Specific
  Presenter(s):Ian Loftus, MD / Pete Holt, MD, PhD  
  View Slides in PDF      
3:12 PM - 3:17 PM Visceral Debranching With A Simple Aortic Endograft Is The Best Way To Treat AAAs In Good Risk Patients: How To Do It Safely
  Presenter(s):Guillermo A. Escobar, MD  
  View Slides in PDF      
3:18 PM - 3:23 PM Update On Maintaining Euglycemia To Decrease Spinal Cord Ischemia With Complex AAA And TAAA Repairs
  Presenter(s):Jade S. Hiramoto, MD  
  View Slides in PDF      
3:24 PM - 3:29 PM Incidence And Etiology Of Cerebrovascular Injuries With Acute TBADs With And Without Treatment
  Presenter(s):Loay S. Kabbani, MD, MHSA  
  View Slides in PDF      
3:30 PM - 3:35 PM EVAR, F/EVAR And B/EVAR Results In Females: Are There Still Differences
  Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD  
  View Slides in PDF      
3:36 PM - 3:41 PM Update On Performing EVAR With Only IVUS Guidance To Decrease Radiation: Technical Tips And 3-Year Results
  Presenter(s):Jörg Tessarek, MD  
  View Slides in PDF      
3:42 PM - 3:47 PM Risk Factors And Late Clinical Consequences Of AAA Neck Dilatation >6 Years After EVAR With Self-Expanding Endografts: Does The Neck Keep Dilating After The Spring Is Gone: What Are The Differences Between Excluder And Endurant Endografts
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
3:48 PM - 3:58 PM Panel Discussion
END OF SESSION 41
 
SESSION 42 SCHEDULE
Wednesday
SESSION 42: MORE SHORT HOT NEW TOPICS RELATED TO AORTIC DISEASE AND ITS TREATMENT AND MISCELLANEOUS TOPICS
x
3:58 PM - 4:03 PM Impact Of Iliac Aneurysms On The Treatment Of Complex AAAs
  Presenter(s):Matthew J. Eagleton, MD  
  View Slides in PDF      
4:04 PM - 4:09 PM How To Treat AAAs With Large (>34 mm Diameter) Necks: When EVAR; When F/EVAR; When Open
  Presenter(s):Rabih A. Chaer, MD  
  View Slides in PDF      
4:10 PM - 4:15 PM A New Gene Family In AAA Smooth Muscle Is Related To Aneurysm Diameter And Rupture: Could It Be A Screening Tool
  Presenter(s):Kak Khee Yeung, MD, PhD  
  View Slides in PDF      
4:16 PM - 4:21 PM How Should Intramural Hematomas (IMHs) In The Ascending Aorta And Arch Be Treated
  Presenter(s):Jennifer L. Perri, MD, MBA / Timothy A.M. Chuter, DM  
  View Slides in PDF      
4:22 PM - 4:27 PM How To Safely Stent The Large Fenestration Of A ZFEN Endograft When It Is Crossed By Struts: Indications For Doing So And Late Results
  Presenter(s):Luis A. Sanchez, MD  
  View Slides in PDF      
4:28 PM - 4:33 PM The Sandwich-Periscope Technique For Left Subclavian Revascularization With Zone 2 TEVAR: It May Be The Best Way And How To Do It
  Presenter(s):Sukgu Han, MD  
  View Slides in PDF      
4:34 PM - 4:39 PM Comparison Of Endo And Open (Carotid-Subclavian Bypass) Treatments For Subclavian Artery Stenosis And Occlusions: Safety, Durability And Costs
  Presenter(s):Ali F. AbuRahma, MD  
  View Slides in PDF      
4:40 PM - 4:46 PM Panel Discussion
MISCELLANEOUS TOPICS
4:46 PM - 4:51 PM Propensity Score Matching Studies: How Do They Work And What Are Their Strengths And Weaknesses
  Presenter(s):Charles C. Miller, PhD  
  View Slides in PDF      
4:52 PM - 4:57 PM The Ever Changing Reimbursement For Lower Extremity Endovascular Therapies In Hospitals And OBLs: Why It’s Happening And Where Is It Going
  Presenter(s):Sean P. Roddy, MD / Robert M. Zwolak, MD, PhD  
  View Slides in PDF      
4:58 PM - 5:03 PM How Can Vascular Surgeons Identify High Risk, High Cost Patients And Help Health Care Systems Control Costs: How To Prevent Inappropriate Treatments In These Patients
  Presenter(s):Lee Kirksey, MD  
  View Slides in PDF      
5:04 PM - 5:09 PM What Obstacles And Blows Are Vascular Surgeons And Other Vascular Specialists Facing In 2021: Will Planned Increased Reimbursement For Office And Hospital Visits Cause Decreases In Procedural Reimbursements
  Presenter(s):Sean P. Roddy, MD  
  View Slides in PDF      
5:10 PM - 5:15 PM What Vascular Injury Killed Martin Luther King, Jr. And Why He Might Have Survived Today
  Presenter(s):Cynthia K. Shortell, MD  
  View Slides in PDF      
5:16 PM - 5:21 PM Historical Perspective Over The Last 25 Years On FDA Approvals Of EVAR Devices Submitted By Investigators And Industry: Lessons Learned To Guide Future Applications
  Presenter(s):Kenneth Ouriel, MD, MBA / Dorothy B. Abel, BSBME  
  View Slides in PDF      
5:22 PM - 5:27 PM Are The Quality, Safety And Effectiveness Of Generic Drugs Equating Those Of The Patented Original Drugs: How Is The FDA Assuring Equivalence; Should The FDA Do More
  Presenter(s):Valerie M. Merkle, PhD  
  View Slides in PDF      
5:28 PM - 5:34 PM Panel Discussion
5:34 PM - 5:39 PM A Balanced View Of Atherectomy In Outpatient Facilities And OBLs In 2020: Is The Procedure Overused And Why
  Presenter(s):Krishna Jain, MD  
  View Slides in PDF      
5:40 PM - 5:45 PM Inherent Conflicts Of Interest In OBLs: Why They Occur And Are Bad For Patients: How To Counteract Them
  Presenter(s):O. William Brown, MD, JD  
  View Slides in PDF      
5:46 PM - 5:51 PM Why And How Do Outpatient Angio Suites And OBLs Fail
  Presenter(s):Sam S. Ahn, MD, FACS, MBA  
  View Slides in PDF      
5:52 PM - 5:57 PM SVS VQI – From Quality Improvement To Disruptive Technology
  Presenter(s):Jens Eldrup-Jorgensen, MD / Jack L. Cronenwett, MD  
  View Slides in PDF      
5:58 PM - 6:03 PM

Power Point Presentation with Synched Audio
Improved Outcomes Of Type A Aortic Dissections With Use Of Bare Stents (Cardiatis And Ascyrus): They Decrease Malperfusion, Promote Aortic Remodeling And Prevent Strokes: How Do They Work
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Slides in PDF      
6:04 PM - 6:10 PM Panel Discussion
6:10 PM - 6:10 PM End of Program D
END OF SESSION 42
 
SESSION 43 SCHEDULE
Thursday
SESSION 43: EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES OR CONCEPTS
x
7:00 AM - 7:05 AM Combating Bias In Medical And Vascular Studies And Therapeutic Decision Making: Why It Is Such A Big Deal And What To Do About It
  Presenter(s):Matthew T. Menard, MD  
  View Slides in PDF      
7:06 AM - 7:11 AM Update On Remote Monitoring Of Vascular Grafts: Where Is It At And Where Is It Going
  Presenter(s):Richard F. Neville, MD  
  View Slides in PDF      
7:12 AM - 7:17 AM Value Of Digital Health In Vascular Disease Management: Virtual And Otherwise
  Presenter(s):Tony S. Das, MD  
  View Slides in PDF      
7:18 AM - 7:23 AM Vascular Surgical Risks Of Shoulder Reconstructive Surgery: What Are They And How Should They Be Managed
  Presenter(s):Jacques Busquet, MD  
  View Slides in PDF      
7:24 AM - 7:29 AM Measuring Aortic Diameters Is Inaccurate And Subjective: Even With Newer Imaging Technology, One Can Make The Diameter What You Want: What Are The Implications
  Presenter(s):Janet T. Powell, MD, PhD  
  View Slides in PDF      
7:30 AM - 7:35 AM The Temporary Perfuse Dual Chamber Stent-Graft For Clamp Free Aortic Surgery, Drug Delivery And Other Uses: How Does It Work
  Presenter(s):Bryan W. Tillman, MD, PhD  
  View Slides in PDF      
7:36 AM - 7:41 AM Non-Compliant Endografts For TEVAR Have A Detrimental Effect On Systolic Blood Pressure And Cardiac Function; Compliant Endografts Are The Remedy
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS / Juan C. Parodi, MD  
  View Slides in PDF      
7:42 AM - 7:47 AM Update On Isolated Limb Perfusion To Enable Amputated Limb Reimplantation
  Presenter(s):Zachary M. Arthurs, MD  
  View Slides in PDF      
7:48 AM - 7:59 AM Panel Discussion
END OF SESSION 43
 
SESSION 44 SCHEDULE
Thursday
SESSION 44: PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
x
8:00 AM - 8:05 AM Lower Extremity Ischemic Complications After F/B/EVAR: Etiology And How To Avoid Them
  Presenter(s):Thomas S. Maldonado, MD  
  View Slides in PDF      
8:06 AM - 8:11 AM F/B/EVAR Treatment Of FAILED EVAR: A Safer Better Way To Treat: How Has The Aortic Research Consortium Helped To Promote Solutions To This And Other Problems
  Presenter(s):Andres Schanzer, MD  
  View Slides in PDF      
8:12 AM - 8:17 AM

Power Point Presentation with Synched Audio
When Is Ch/EVAR Indicated And Equally Effective To F/EVAR For Juxta And Pararenal AAAs In Terms Of Outcomes And Cost: Why Are Opinions On Ch/EVAR So Divergent
  Presenter(s):Konstantinos P. Donas, MD  
  View Slides in PDF      
8:18 AM - 8:23 AM Fenestrated EVAR: Techniques And Outcomes With Physician Modification And Their Impact On A New IDE Pivotal Study
  Presenter(s):Benjamin W. Starnes, MD  
  View Slides in PDF      
8:24 AM - 8:29 AM Mortality From Aneurysm Rupture While Waiting For A Customized F/B/EVAR Endograft: Strategy To Prevent: Are There Reasons For Open Repairs In A High Volume F/B/EVAR Center
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
8:30 AM - 8:35 AM Why Balloon Expandable Bridging Stent-Grafts Are Best For F/B/EVAR: Which One Is Best And Why: A US Perspective
  Presenter(s):Mark A. Farber, MD  
  View Slides in PDF      
8:36 AM - 8:41 AM

Power Point Presentation with Synched Audio
What Is The Best Bridging Covered Stent (Stent-Graft) For F/B/EVAR Based On An In Vitro Fatigue Testing Model And Other Considerations
  Presenter(s):Martin J. Austermann, MD  
  View Slides in PDF      
8:42 AM - 8:47 AM How To Safely And Effectively Treat TAAAs With Off-The-Shelf (OTS) Devices Including Chimney And Sandwich Stent-Grafts: The Docking Station Approach: How To Do It And Midterm Results
  Presenter(s):Manish Mehta, MD, MPH  
  View Slides in PDF      
8:48 AM - 9:03 AM Panel Discussion
9:04 AM - 9:38 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 44
 
SESSION 45 SCHEDULE
Thursday
SESSION 45: MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
x
9:38 AM - 9:43 AM Percutaneous Femoral And Axillary Access For Complex Endovascular AAA Repair: How To Do It Safely And To Safely Downsize Femoral Sheaths To Restore Lower Extremity Flow
  Presenter(s):Darren B. Schneider, MD  
  View Slides in PDF      
9:44 AM - 9:49 AM Present Status Of Parallel Grafts For Complex AAAs And TAAAs: How To Do These Repairs Safely And Effectively: Results To Date
  Presenter(s):Armando C. Lobato, MD, PhD  
  View Slides in PDF      
9:50 AM - 9:55 AM Value And Advantages Of Preloaded Wires And Catheters For F/B/EVAR: How Do They Work; Are There Pitfalls
  Presenter(s):Mark A. Farber, MD  
  View Slides in PDF      
9:56 AM - 10:01 AM DEBATE: The Case Against Ch/EVAR And Parallel Grafts For Complex AAA And TAAA Repairs: F/B/EVAR Is Much Better
  Presenter(s):Adam Beck, MD  
  View Slides in PDF      
10:02 AM - 10:07 AM DEBATE: Nonsense! Ch/EVAR And Parallel Grafts If Done Right Are As Safe And Effective As F/B/EVAR And In Some Cases Better And Cheaper
  Presenter(s):Edward Y. Woo, MD  
  View Slides in PDF      
10:08 AM - 10:13 AM F/EVAR Is Sometimes Justified In Patients >80: How About >90
  Presenter(s):Clark J. Zeebregts, MD, PhD  
  View Slides in PDF      
10:14 AM - 10:19 AM DEBATE: Increasing The Number Of Fenestrations In F/EVAR Beyond 2 Improves Outcomes Without Increasing Downsides
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
  View Slides in PDF      
10:20 AM - 10:25 AM DEBATE: Not So! 2 Branch F/EVAR Is Sometimes Better And Has Fewer Complications And Downsides In Some Cases: Which Ones
  Presenter(s):Timothy A. Resch, MD, PhD  
  View Slides in PDF      
10:26 AM - 10:31 AM Advantages Of Steerable (Variable Curve) Sheaths For Complex AAA And TAAA Repairs And TBADs: Which One Is Best And Why: Pitfalls And How To Prevent Them
  Presenter(s):W. Anthony Lee, MD  
  View Slides in PDF      
10:32 AM - 10:42 AM Panel Discussion
END OF SESSION 45
 
SESSION 46 SCHEDULE
Thursday
SESSION 46: A TRIBUTE TO OUR MILITARY AND MILITARY PHYSICIANS: SOME MILITARY HISTORY; TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES AND CONTROL OF HEMORRHAGE; INNOVATIVE TECHNOLOGIES SUPPORTED BY THE DEFENSE DEPARTMENT
x
10:42 AM - 10:54 AM The Vietnam Battle Of Ia Drang (November 14-16, 1965): Why Was It Fought And Why Was It Significant (12-Minute Talk)
  Presenter(s):Wayne F. Yakes, MD  
  View Slides in PDF      
10:55 AM - 11:01 AM Department of Defense Effort To Support Vascular Surgery Research And US National Preparedness For Mass Casualties
  Presenter(s):Todd E. Rasmussen, MD, FACS  
  View Slides in PDF      
11:02 AM - 11:08 AM Update On Endovascular Resuscitation And Control Of Bleeding: What Is New And Different: What Is The EVTM Society
  Presenter(s):Tal M. Hoerer, MD, PhD  
  View Slides in PDF      
11:09 AM - 11:15 AM Update On Civilian REBOA (Resuscitative Endovascular Balloon Occlusion Of The Aorta) For Treatment Of Hemorrhage And Trauma: What Is New And Different: When And Where Should It Be Used And By Whom
  Presenter(s):Joseph J. DuBose, MD  
  View Slides in PDF      
11:16 AM - 11:22 AM Is REBOA A Panacea For Battlefield Hemorrhage Or Not Yet Ready For Prime Time Use
  Presenter(s):Brandon Propper, MD / Zachary M. Arthurs, MD / Todd E. Rasmussen, MD, FACS  
  View Slides in PDF      
11:23 AM - 11:29 AM Current Advances In The Treatment Of Blast And High Velocity Gun Shot Injuries
  Presenter(s):Paul W. White, MD  
  View Slides in PDF      
11:30 AM - 11:36 AM Update On The Retrievable Rescue Stent Graft To Control Massive Aortic Or Caval Bleeding: How Does It Work And Present Status
  Presenter(s):Bryan W. Tillman, MD, PhD  
  View Slides in PDF      
11:37 AM - 11:43 AM Major Amputation Prosthetics Can Be Fixed Into Bone: How Does Osteointegration Work And How Is Infection Avoided
  Presenter(s):Zachary M. Arthurs, MD / Todd E. Rasmussen, MD, FACS  
  View Slides in PDF      
11:44 AM - 11:50 AM Update On Tissue Engineered Biological Arterial Grafts (Humacyte): How Well Are They Working In Patients And In What Vascular Bed
  Presenter(s):Jeffrey H. Lawson, MD, PhD  
  View Slides in PDF      
11:51 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 46
 
SESSION 47 SCHEDULE
Thursday
SESSION 47: PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs, COMPLEX AAAs, TAAAs AND RELATED TOPICS
x
1:00 PM - 1:05 PM Value, Limitations And Technical Tips For Using The Nellix Endograft For Ruptured AAAs
  Presenter(s):Tal M. Hoerer, MD, PhD  
  View Slides in PDF      
1:06 PM - 1:11 PM The Incidence Of Ruptured AAAs Is Decreasing And So Is Their Mortality: Why Are These 2 Facts So
  Presenter(s):Ross Milner, MD  
  View Slides in PDF      
1:12 PM - 1:17 PM Statins Decrease The Growth Rate And Rupture Risk Of AAAs As Well As The Perioperative Mortality: Who Should Receive Them, When And At What Dose
  Presenter(s):Thomas L. Forbes, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM Impact Of Weekends On Treatment Method (Endo Versus Open Repair) And Outcomes (Early And Late) Of Treatment For Ruptured AAAs
  Presenter(s):Sebastian E. Debus, MD, PhD  
  View Slides in PDF      
1:24 PM - 1:29 PM Long-Term Results Of The AJAX RCT Comparing EVAR With Open Repair For Ruptured AAAs: EVAR Wins In The End – Especially In Patients >80
  Presenter(s):Willem Wisselink, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM Variation In Use Of EVAR Versus Open Repair For Ruptured AAAs Depends On Training And Bias Rather Than Data Logic Or Facts: EVAR Is Clearly The Best Treatment If It Can Be Done
  Presenter(s):Martin Malina, MD, PhD  
  View Slides in PDF      
1:36 PM - 1:41 PM Emergency Treatment As Aortic Rupture From Chronic TBAD Using The Candy Plug Technique: Technical Tips And Results
  Presenter(s):Daniela Branzan, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM EVAR Is A Better Treatment For Ruptured AAAs Than Open Repair In Most Patients: The Mortality Benefit Of EVAR Is Increasing More Recently: Based On A Meta-Analysis
  Presenter(s):George A. Antoniou, MD, PhD, MSc, FEBVS  
  View Slides in PDF      
1:48 PM - 1:53 PM DEBATE: With Ruptured Complex AAAs And TAAAs, Off-The-Shelf F/B/EVAR Is The Best Treatment
  Presenter(s):Mark A. Farber, MD  
  View Slides in PDF      
1:54 PM - 1:59 PM

Power Point Presentation with Synched Audio
DEBATE: Not So: With Ruptured Complex AAAs And TAAAs Parallel Grafts Are Simpler, More Effective And Less Costly
  Presenter(s):Konstantinos P. Donas, MD  
  View Slides in PDF      
2:00 PM - 2:06 PM Panel Discussion
END OF SESSION 47
 
SESSION 48 SCHEDULE
Thursday
SESSION 48: MORE NEW DEVELOPMENTS IN RUPTURED AAAs AND TAAAs; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING
x
NEW DEVELOPMENTS IN AAA SCREENING
2:06 PM - 2:11 PM Why The Current US PSTF Guidelines For AAA Screening Are Insufficient: Many At Risk Patients Are Not Screened
  Presenter(s):Malachi Sheahan, MD  
  View Slides in PDF      
2:12 PM - 2:17 PM Update On Current Screening For AAAs In The US: Most Ruptured AAAs Occur In Patients Not Being Screened: How Should US PSTF Recommendations Be Changed
  Presenter(s):Marc L. Schermerhorn, MD  
  View Slides in PDF      
2:18 PM - 2:23 PM Flaws In AAA Screening In Finland Result In AAA Ruptures In Patients Too Young For Screening And Whose AAAs Are Too Small To Reach Threshold For Repair
  Presenter(s):Maarit Venermo, MD, PhD  
  View Slides in PDF      
2:24 PM - 2:29 PM Why AAA Screening Should Be Expanded To More Females, Younger Men And Older Men
  Presenter(s):Thomas F.X. O'Donnell, MD  
  View Slides in PDF      
MORE ABOUT AAA RUPTURES AND THEIR TREATMENT
2:30 PM - 2:35 PM AAA Rupture After EVAR Behaves Differently From De Novo Rupture: How Should Treatment Be Modified In Patients With Post EVAR Ruptures
  Presenter(s):Piotr Szopinski, MD, PhD  
  View Slides in PDF      
2:36 PM - 2:41 PM Update On Treating All (100%) Ruptured AAAs With EVAR: The Orebro And Zurich Experience Shows It Is The Best Treatment And Lowers The Turndown Rate
  Presenter(s):Mario L. Lachat, MD / David T. McGreevy, MD / Thomas Larzon, MD, PhD  
  View Slides in PDF      
2:42 PM - 2:47 PM Update On Status Of Retrograde And Prograde In Site Fenestration For Arch Aneurysms And TAAAs: How To Do Them
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
2:48 PM - 2:53 PM Open Repair For AAAs Should Not Be Used In Patients >80 Unless Their AAA Is >6 cm And They Are At Risk Of Rupture Or Ruptured: These Restrictions Do Not Apply To EVAR
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
  View Slides in PDF      
2:54 PM - 2:59 PM When Should Ruptured AAA Patients Be Transferred: Should They Ever Be Denied Invasive Treatment
  Presenter(s):Matthew W. Mell, MD, MS  
  View Slides in PDF      
3:00 PM - 3:10 PM Panel Discussion
3:10 PM - 3:30 PM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 48
 
SESSION 49 SCHEDULE
Thursday
SESSION 49: EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS
x
3:30 PM - 3:35 PM The No Intervention Option For Treatment Is More Commonly Elected For Women Than Men With CLTI, AAAs, Ruptured AAAs And Thoracic Aneurysms: It Is Wrong Headed And Unfair
  Presenter(s):Janet T. Powell, MD, PhD  
  View Slides in PDF      
3:36 PM - 3:41 PM

Power Point Presentation with Synched Audio
Transradial Approaches For Complex Lower Extremity Interventions: CTSOs, Iliac, Fempop And BTK Lesions Can Be Treated: How To Make Them Work And Precautions: Advantages Of The Terumo R2P System
  Presenter(s):David O'Connor, MD  
  View Slides in PDF      
3:41 PM - 3:42 PM Transcatheter Bariatric Embolotherapy: Early And Long-Term Results From A Randomized Study
  Presenter(s):Nicholas Kipshidze, MD, PhD, DSc  
  View Slides in PDF      
3:48 PM - 3:53 PM

Power Point Presentation with Synched Audio
The Spur Stent System (Reflow Medical): A Temporary Stent With Pins To Penetrate The Arterial Wall And Facilitate DCB Drug Delivery: How Does It Work And Results To Date
  Presenter(s):Marianne Brodmann, MD / Andrew Holden, MBChB / Thomas Zeller, MD  
  View Slides in PDF      
3:54 PM - 3:59 PM

Power Point Presentation with Synched Audio
The Serranator Balloon Catheter (From Cagent Vascular) For Vessel Prep In BTK Arteries: It Makes Microserrations And Prevents Dissections With PTA: Current Status: The PRELUDE BTK Trial
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
4:00 PM - 4:05 PM What Is The OR Black Box System For Measuring Endovascular Operator Performance: How Does It Work And Should It Be In Every Hybrid Angio Suite
  Presenter(s):Isabelle Van Herzeele, MD, PhD  
  View Slides in PDF      
4:06 PM - 4:11 PM Update On A Clampless Sutureless Technique For Performing Aorto-Iliac Anastomosis Using Endograft Connectors: The VORTEC Technique – Useful When Arterial Control And Suturing Is Impossible
  Presenter(s):Mario L. Lachat, MD  
  View Slides in PDF      
4:12 PM - 4:17 PM Technical Tips For Safe Endovascular Treatment Of Hepatic Artery Stenosis After Liver Transplantation
  Presenter(s):W. Charles Sternbergh III, MD  
  View Slides in PDF      
4:18 PM - 4:23 PM Current Status Of Left Gastric Embolization To Treat Obesity: Where Is It And What Will Its Role Be
  Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI  
  View Slides in PDF      
4:24 PM - 4:29 PM The Many Possible Uses Of Femoral Veins For Arterial Procedures: How To Harvest Them Safely
  Presenter(s):Timur P. Sarac, MD  
  View Slides in PDF      
4:30 PM - 4:38 PM Panel Discussion
END OF SESSION 49
 
SESSION 50 SCHEDULE
Thursday
SESSION 50: PROGRESS IN RADIATION SAFETY AND MORE NEW CONCEPTS, DEVICES AND TECHNIQUES
x
PROGRESS IN RADIATION SAFETY
4:38 PM - 4:43 PM Endovascular Team Radiation Safety Performance: How To Monitor It: It Is More Than Dose Measurement
  Presenter(s):Isabelle Van Herzeele, MD, PhD  
  View Slides in PDF      
4:44 PM - 4:49 PM What Is New In Radiation Safety: ESVS Radiation Safety Guidelines And Why Chromosomal Aberrations In High Volume Endovascular Operators Matters
  Presenter(s):Bijan Modarai, PhD, FRCS  
  View Slides in PDF      
4:50 PM - 4:55 PM Simple Radiation Protection Techniques For All Interventionalists To Use
  Presenter(s):Ripal T. Gandhi, MD, FSVM, FSIR  
  View Slides in PDF      
NEW CONCEPTS, ETC.
4:56 PM - 5:01 PM Endovascular Emergency Treatment Of Carotid Blowout From Head And Neck Cancer Or Carotid Patch Infections: Planning, Preparation And Technical Tips Are Essential
  Presenter(s):Michael B. Silva, Jr., MD  
  View Slides in PDF      
5:02 PM - 5:07 PM Value Of Repetitive Digital Photo Documentation Of The Ischemic Foot: It Improves Decisions And Outcomes
  Presenter(s):Martin Malina, MD, PhD  
  View Slides in PDF      
5:08 PM - 5:13 PM COVID-19 Virus Has Been Identified In Periaortic Fat: What Is Its Significance
  Presenter(s):Kak Khee Yeung, MD, PhD  
  View Slides in PDF      
5:14 PM - 5:25 PM Panel Discussion
5:25 PM - 5:25 PM End of Program E
END OF SESSION 50
 
SESSION 51 SCHEDULE
Thursday
SESSION 51: NEW OR IMPROVED DEVICES FOR INFRARENAL AAA REPAIR WITH STANDARD EVAR (5-MINUTE TALKS)
x
7:00 AM - 7:05 AM Treo Endograft (Terumo Aortic) For Standard Infrarenal EVAR: Approval In US And Japan
  Presenter(s):Matthew J. Eagleton, MD  
  View Slides in PDF      
7:06 AM - 7:11 AM

Power Point Presentation with Synched Audio
Real World Outcomes With The TREO Endograft (Terumo Aortic): Preliminary Results From The TIGER Registry
  Presenter(s):Vicente Riambau, MD, PhD  
  View Slides in PDF      
7:12 AM - 7:17 AM Status In The US Of The Gore Conformable Excluder With Variable Neck Angulation Control For AAAs With Imperfect Necks
  Presenter(s):Robert Y. Rhee, MD  
  View Slides in PDF      
7:18 AM - 7:23 AM Status Of The Gore Conformable Excluder For EVAR In Europe: Results From The EXCEL And BSET Registries
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD / Colin D. Bicknell, MD, FRCS  
  View Slides in PDF      
7:24 AM - 7:29 AM When Does The Gore Conformable Excluder For EVAR Really Make A Difference: How Does It Work
  Presenter(s):Richard G.J. Gibbs, FRCS / Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
  View Slides in PDF      
7:30 AM - 7:35 AM Altura Endograft With Kissing Proximal Stents For Standard EVAR: Advantages And Limitations: From An Experience With 150 Patients And Up To 5-Year Follow-Up
  Presenter(s):Dainis K. Krievins, MD  
  View Slides in PDF      
7:36 AM - 7:41 AM Advantages And Limitations Of The Cook ZENITH Alpha Endograft For EVAR: Based On European Multicenter Experience
  Presenter(s):Philippe W.M. Cuypers, MD, PhD / Marc R.H.M. van Sambeek, MD, PhD  
  View Slides in PDF      
7:42 AM - 7:47 AM How And Why Do The Endurant Endograft Results For EVAR In France Differ From The Global Results: What Are The Implications
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
  View Slides in PDF      
7:48 AM - 7:53 AM AAA Repairs With The Endurant Endograft Outside The IFU Can Provide Acceptable Results In Some Patients: When Is This So And When Not
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD  
  View Slides in PDF      
7:54 AM - 7:59 AM Update On The LEOPARD RCT Results Show That AFX Endografts Compare Favorably To Standard Proximally Fixed Endografts For AAA Repair
  Presenter(s):Christopher J. Kwolek, MD, MBA  
  View Slides in PDF      
8:00 AM - 8:12 AM Panel Discussion
END OF SESSION 51
 
SESSION 52 SCHEDULE
Thursday
SESSION 52: NEW OR UPDATED DEVICES FOR STANDARD EVAR, EVAS (ENDOVASCULAR ANEURYSM SEALING) AND F/EVAR
x
8:12 AM - 8:17 AM Alto Endograft (From Endologix) For Standard EVAR: This Latest Modification Of The Ovation Endograft Has More Proximal Polymer Sealing Rings: Results From The ELEVATE Trial And 3-4-Year Results From The New Zealand Experience Show Advantages
  Presenter(s):Sean P. Lyden, MD / Andrew Holden, MBChB  
  View Slides in PDF      
8:18 AM - 8:23 AM Combination Of Ovation Endograft And Bare Metal Renal Stent For Difficult AAA Neck Unsuitable For F/EVAR
  Presenter(s):Gianmarco de Donato, MD  
  View Slides in PDF      
8:24 AM - 8:29 AM Experience With The Nellix Endograft In 120 Patients With Up To 10 Years Follow-Up: What Is The Devices’ Future
  Presenter(s):Dainis K. Krievins, MD  
  View Slides in PDF      
8:30 AM - 8:35 AM Update On Multicenter Results With F/EVAR Using The Fenestrated Anaconda Endograft: From The Global FACT Registry: Advantages And Limitations
  Presenter(s):Clark J. Zeebregts, MD, PhD / Michel M.P. Reijnen, MD, PhD  
  View Slides in PDF      
8:36 AM - 8:41 AM

Power Point Presentation with Synched Audio
Update On The Incraft Endograft For Standard Infrarenal EVAR: Is Its Low Profile An Advantage
  Presenter(s):Matteo Orrico, MD  
  View Slides in PDF      
8:42 AM - 8:47 AM Long-Term Outcomes Of The Cook pBranch OTS Device For F/EVAR: Advantages And Limitations
  Presenter(s):Timothy A. Resch, MD, PhD  
  View Slides in PDF      
8:48 AM - 8:58 AM Panel Discussion
8:58 AM - 9:24 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 52
 
SESSION 53 SCHEDULE
Thursday
SESSION 53: NEW OR IMPROVED DEVICES FOR THE ASCENDING AORTA, THE AORTIC ARCH OR NEAR THE ARCH
x
9:24 AM - 9:29 AM Nexus OTS Endograft From Endospan For Treating Zone 1 Lesions Of The Aortic Arch: How Does It Work And 2-Year Clinical Results: Status In The US
  Presenter(s):Ross Milner, MD / Daniel G. Clair, MD / Andrew Holden, MBChB  
  View Slides in PDF      
9:30 AM - 9:35 AM

Power Point Presentation with Synched Audio
Outcomes Of The Custom Relay Ascending Aorta Endograft (Terumo Aortic): The European Experience
  Presenter(s):Vicente Riambau, MD, PhD / Afshin Assadian, MD / Mo S. Hamady, MD, FRCR, EBIR, FSIR  
  View Slides in PDF      
9:36 AM - 9:41 AM Status In The US Of The RelayBranch Investigational Device For Repair Of Aortic Arch Lesions: How Many Branches Can And Should Be Revascularized: Advantages And Limitations
  Presenter(s):Luis A. Sanchez, MD / Eric E. Roselli, MD  
  View Slides in PDF      
9:42 AM - 9:47 AM

Power Point Presentation with Synched Audio
Long-Term Safety And Durable Effectiveness Of Relay (Terumo Aortic) Scalloped Endograft For TEVAR Treatment Of Lesions In Or Near The Aortic Arch
  Presenter(s):Mo S. Hamady, MD, FRCR, EBIR, FSIR / Jean-Marc Alsac, MD, PhD  
  View Slides in PDF      
9:48 AM - 9:53 AM Status In The US Of The Gore Conformable CTAG Endograft With Variable Angulation Control In The Aortic Arch: How Does It Work And Advantages
  Presenter(s):Jean Bismuth, MD  
  View Slides in PDF      
9:54 AM - 9:59 AM When And How To Use The Gore Conformable CTAG Endograft Optimally: Are There Downsides
  Presenter(s):Sukgu Han, MD  
  View Slides in PDF      
10:00 AM - 10:05 AM Indications, Value And Limitations Of Single Branched TEVAR Devices For Revascularizing The Left Subclavian Artery: Are They Worth The Effort And Cost
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
10:06 AM - 10:15 AM Panel Discussion
END OF SESSION 53
 
SESSION 54 SCHEDULE
Thursday
SESSION 54: NEW OR IMPROVED DEVICES FOR THORACIC AORTIC LESION REPAIRS (TEVAR) AND FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS (ALL TALKS ARE 4 ¾-MINUTES)
x
DEVICES FOR TEVAR
10:15 AM - 10:20 AM Low Profile Devices For TEVAR: Advantages And Disadvantages Based On Long-Term Results
  Presenter(s):Giovanni B. Torsello, MD  
  View Slides in PDF      
10:20 AM - 10:25 AM

Power Point Presentation with Synched Audio
6-Year Experience With The Cook ZENITH Alpha Thoracic Endograft For TEVAR In 400 Patients: How To Achieve Long-Term Durably Good Results
  Presenter(s):Germano Melissano, MD  
  View Slides in PDF      
10:25 AM - 10:30 AM Long-Term Outcomes Of TEVAR For Repair Of Traumatic Aortic Injuries From The RESCUE U.S. IDE Clinical Trial
  Presenter(s):Ali Azizzadeh, MD  
  View Slides in PDF      
10:30 AM - 10:35 AM Endoanchors To Improve Outcomes With TEVAR: They Can Help Distally As Well As Proximally
  Presenter(s):Ross Milner, MD  
  View Slides in PDF      
10:35 AM - 10:40 AM Tips And Tricks Of Endoanchors Application After TEVAR (TESAR)
  Presenter(s):Giovanni Tinelli, MD, PhD / Yamume Tshomba, MD  
  View Slides in PDF      
10:40 AM - 10:46 AM Panel Discussion
10:46 AM - 10:51 AM The Relay Pro (Terumo Aortic) Endograft For TEVAR And Its Advantages In Treating TBADs: Why Is It Better Than The Older Relay Plus Device
  Presenter(s):Edward Y. Woo, MD / Steven D. Abramowitz, MD  
  View Slides in PDF      
10:51 AM - 10:56 AM Patient Specific Custom Designed Relay Pro Endografts (Terumo Aortic): How Do They Work And What Are Their Advantages In Various Circumstances
  Presenter(s):David M. Williams, MD  
  View Slides in PDF      
10:56 AM - 11:01 AM

Power Point Presentation with Synched Audio
Relay Endografts (Terumo Aortic) For TEVAR: Why Do They Provide Better Wall Apposition For Sealing
  Presenter(s):Fadi Taher, MD / Afshin Assadian, MD  
  View Slides in PDF      
11:01 AM - 11:06 AM

Power Point Presentation with Synched Audio
European Experience With The Gore CTAG Conformable Endograft For TEVAR With Variable Angulation Control Proximally: When And How Does It Improve Results
  Presenter(s):Vicente Riambau, MD, PhD  
  View Slides in PDF      
11:06 AM - 11:11 AM New Polymer Filled Low Profile Endograft Device With O-Ring Sealing: How Does It Work And Why Is It Better
  Presenter(s):Piotr Szopinski, MD, PhD  
  View Slides in PDF      
11:11 AM - 11:17 AM Panel Discussion
NEW OR IMPROVED ENDO DEVICES FOR TAAA REPAIRS
11:17 AM - 11:22 AM To Treat Complex TAAAs A Combination Of A Relay (Terumo) TEVAR And A Fenestrated Anaconda Is Best: How Are The SMA And Celiac Axis Revascularized
  Presenter(s):Mo S. Hamady, MD, FRCR, EBIR, FSIR  
11:22 AM - 11:27 AM Status Of The Cook t-Branch OTS Endograft For TAAA Repairs: Advantages And Limitations Based On A Meta-Analysis
  Presenter(s):Nikolaos Tsilimparis, MD, PhD  
  View Slides in PDF      
11:27 AM - 11:32 AM

Power Point Presentation with Synched Audio
Comparison Of 3 OTS Endografts For Urgent TAAA Repairs: TAMBE (Gore) Versus E-nside (Jotec) Versus t-Branch (Cook): Advantages And Disadvantages Of Each
  Presenter(s):Luca Bertoglio, MD / Germano Melissano, MD / Roberto Chiesa, MD  
  View Slides in PDF      
11:32 AM - 11:37 AM Valiant Manifold OTS Endograft (Medtronic) Device For Repairing TAAAs: How Does It Work And Early Clinical Experience In The US
  Presenter(s):Murray L. Shames, MD  
  View Slides in PDF      
11:37 AM - 11:42 AM Unitary Manifold Endograft System For Complex Type 4 TAAAs And Failed EVARs: How Does It Work And 2-Year Results
  Presenter(s):Patrick W. Kelly, MD  
  View Slides in PDF      
11:42 AM - 11:47 AM

Power Point Presentation with Synched Audio
Novel OTS Life Tech Endograft For TAAA Repair: How Does It Work And What Makes It Different
  Presenter(s):Ralf R. Kolvenbach, MD  
  View Slides in PDF      
11:48 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 54
 
SESSION 55 SCHEDULE
Thursday
SESSION 55: NEW OR UPDATED INFORMATION ON BALLOON EXPANDABLE COVERED STENTS, LOWER EXTREMITY PROSTHETIC GRAFTS, BIORESORBABLE GRAFTS, PERIGRAFT SEROMA AND VALUE OF A PROSTHETIC PERIGRAFT SIROLIMUS PATCH [SEE ALSO SESSION 28] ALL TALKS ARE 5 MINUTES)
x
STENT-GRAFTS
1:00 PM - 1:05 PM Why Are VBX Balloon Expandable Stent-Grafts (From Gore) Different And Better Than Other Covered Stents In Various Vascular Beds
  Presenter(s):James F. McKinsey, MD  
  View Slides in PDF      
1:06 PM - 1:11 PM Safety Of MRI Early After Deployment Of Various Covered Stents
  Presenter(s):Maria A. Ruffino, MD, EBIR  
  View Slides in PDF      
PROSTHETIC GRAFTS
1:12 PM - 1:17 PM Final 3-Year Results Of The ZILVERPASS RCT Comparing Prosthetic PTFE Bypasses With Zilver PTX (Cook) Stents To Treat Long Fempop Lesions: Should Open Prosthetic Bypass Be Abandoned
  Presenter(s):Michel J. Bosiers, MD / Marc Bosiers, MD  
  View Slides in PDF      
1:18 PM - 1:23 PM The 3DH Spiral Flow Prosthetic Graft: Does It Prevent Neointimal Hyperplasia In Leg Bypasses Or A-V Access
  Presenter(s):Hosam F. El Sayed, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM Heparin Coated (Propaten) PTFE Grafts (Gore) Versus Autologous Vein Grafts For Bypasses To Targets Above And Below The Knee: Are The Heparin Coated Grafts Worth The Cost
  Presenter(s):David J. Dexter, MD  
  View Slides in PDF      
1:30 PM - 1:35 PM

Power Point Presentation with Synched Audio
Bioabsorbable Arterial Grafts (Xeltis Grafts): How Do They Work And What Is Their Potential
  Presenter(s):Frans L. Moll, MD, PhD  
  View Slides in PDF      
1:36 PM - 1:41 PM Perigraft Seromas After PTFE Lower Extremity And Aortic Arterial Grafts: Frequency, Etiology And What To Do About Them
  Presenter(s):Jae S. Cho, MD  
  View Slides in PDF      
1:42 PM - 1:47 PM Update On External Sirolimus Patch Wrap-Around For PTFE Graft Anastomoses: Do They Decrease Neointimal Hyperplasia
  Presenter(s):Sriram S. Iyer, MD, FACC  
  View Slides in PDF      
1:48 PM - 1:54 PM Panel Discussion
END OF SESSION 55
 
SESSION 56 SCHEDULE
Thursday
SESSION 56: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, TACKS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
x
ATHERECTOMY RELATED TOPICS
1:54 PM - 1:59 PM Complications Of Atherectomy: How To Prevent Some, How To Treat The Others
  Presenter(s):Theodosios Bisdas, MD  
2:00 PM - 2:05 PM Value And Limitations Of 355 nm Auryon B-LaserTM (From AngioDynamics): It Enables Safe Crossing Of Difficult Lesions Not Crossed With A Guidewire: How Does It Work And Clinical Results
  Presenter(s):Luis R. Leon, MD, RVT, FACS  
  View Slides in PDF      
2:06 PM - 2:11 PM Orbital And Laser Atherectomy: Indications, Advantages And Precautions With Above Knee BTK De Novo Lesions And ISR
  Presenter(s):Craig M. Walker, MD  
  View Slides in PDF      
2:12 PM - 2:17 PM Value Of Atherectomy And DCBs: Interim Results Of The REALITY Trial
  Presenter(s):Brian G. DeRubertis, MD  
  View Slides in PDF      
ANCILLARY TECHNIQUES
2:18 PM - 2:23 PM Value of Wingman Catheter (Reflow Medical) For Crossing Difficult Lesions: How Does It Work And Results
  Presenter(s):John R. Laird, MD  
  View Slides in PDF      
2:24 PM - 2:29 PM Value of New Dedicated Special Tools And Devices To Facilitate Trans-Radial Access For Lower Extremity Lesion Treatments: How Far Distally Can It Be Effective
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi)  
  View Slides in PDF      
NEW INFORMATION ON STENTS
2:30 PM - 2:35 PM Advantages Of Supera (Vasculomimetic – VMI) Stent For Complex Fempop Occlusive Lesions: Technical Tips: They Work Even In The Subintimal Position
  Presenter(s):Erwin Blessing, MD  
  View Slides in PDF      
2:36 PM - 2:41 PM Value Of The Supera VMI Stent For Common Femoral Artery (CFA) Occlusive Lesions: Better Than Endarterectomy: 2-Year Results And Status Of The SUPERSURG RCT (Versus Open Surgery)
  Presenter(s):Brian G. DeRubertis, MD  
  View Slides in PDF      
2:42 PM - 2:52 PM Panel Discussion
2:52 PM - 3:12 PM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 56
 
SESSION 57 SCHEDULE
Thursday
SESSION 57: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOONS
x
3:12 PM - 3:17 PM

Power Point Presentation with Synched Audio
Chocolate Touch DCBs (From Medtronic): How Do They Work, Advantages And Updated Clinical Results
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
3:18 PM - 3:23 PM

Power Point Presentation with Synched Audio
Unfavorable Balloon (Candy) Wrap Can Cause Dissections With Angioplasty: What Is The Mechanism: How Can It Be Recognized And Dissection Avoided: The Chocolate DCB Is One Way
  Presenter(s):Jos C. van den Berg, MD, PhD  
  View Slides in PDF      
3:24 PM - 3:29 PM

Power Point Presentation with Synched Audio
Update On The TANGO Trial Using The Bullfrog Balloon Device (Mercator Medical Systems) To Inject Sirolimus Drug Into Lesion Wall Before Angioplasty: How Does It Work And Results
  Presenter(s):Ehrin Armstrong, MD  
  View Slides in PDF      
3:30 PM - 3:35 PM

Power Point Presentation with Synched Audio
The Importance Of Dissection In Angioplasty Treatment Of BTK Lesions: How To Prevent And Treat Such Dissections: The Value Of Tacks (From Intact Vascular): How Do They Work
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
3:36 PM - 3:41 PM 24-Month Results Of TOBA II BTK Trial Of The Tack Device To Decrease Dissections With Balloon Angioplasty Of BTK Lesions Show Safety And 94.7% Target Limb Salvage
  Presenter(s):Patrick J. Geraghty, MD  
  View Slides in PDF      
3:42 PM - 3:49 PM Panel Discussion
END OF SESSION 57
 
SESSION 58 SCHEDULE
Thursday
SESSION 58: NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC.
x
3:49 PM - 3:54 PM Prophylactic Endoanchors (Medtronic) With TEVAR For Complex Anatomy Improves Outcomes: Technical Tips For Their Use In TEVAR
  Presenter(s):Jean M. Panneton, MD  
  View Slides in PDF      
3:55 PM - 4:00 PM New Developments From The ANCHOR Registry With Over 5 Years Of Follow-Up Show The Value Of Endoanchors When Used Prophylactically For Certain Indications Prevent Endoleaks And Migration: What Are Those Indications
  Presenter(s):William D. Jordan Jr., MD  
  View Slides in PDF      
4:01 PM - 4:06 PM

Power Point Presentation with Synched Audio
New Developments From The ANCHOR Registry With >5 Years Follow-Up Show That Endoanchors Can Be Used To Treat Endoleaks And Migration Effectively In Hostile Neck Anatomy: The Proof
  Presenter(s):Jean-Paul de Vries, MD, PhD  
  View Slides in PDF      
4:07 PM - 4:12 PM Vesteck – The Next Generation Of Endoanchor Technology: How Does It Work And Where Does It Stand
  Presenter(s):David H. Deaton, MD, FACS  
  View Slides in PDF      
4:13 PM - 4:18 PM Balloon Optimized Molding For Better Deployment And Sealing Of Ovation Alto Low Profile Endografts For EVAR: How To Do It And How It Helps Prevent Endoleaks and Migration
  Presenter(s):David J. Minion, MD  
  View Slides in PDF      
4:19 PM - 4:25 PM Panel Discussion
END OF SESSION 58
 
SESSION 59 SCHEDULE
Thursday
SESSION 59: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
x
CLOT REMOVING DEVICES
4:25 PM - 4:30 PM Percutaneous Embolectomy Or Thrombectomy With The Indigo System (From Penumbra): What Makes It Different, Technical Tips, Results And Limitations
  Presenter(s):David J. Dexter, MD  
  View Slides in PDF      
4:31 PM - 4:36 PM Newer Pharmaco-Mechanical Endovascular Clot Removal Systems: When And Why Is Each Device Best To Use
  Presenter(s):Guillermo A. Escobar, MD  
  View Slides in PDF      
4:37 PM - 4:42 PM

Power Point Presentation with Synched Audio
Catheter Based Vacuum Assisted Thrombectomy For Acute Limb Ischemia: How Does It Work: Advantages And Limitations: From A Multicenter Study: Key Findings From The INDIAN Trial
  Presenter(s):Gianmarco de Donato, MD / Carlo Setacci, MD  
  View Slides in PDF      
4:43 PM - 4:48 PM Technical Tips For Effective Coil Embolization: Importance Of Dense Packing; Coils With Fibers Versus Plain Metal Coils; Value And Indications For Different Coils
  Presenter(s):James F. Benenati, MD / Constantino Pena, MD  
  View Slides in PDF      
4:49 PM - 4:54 PM Why Ruby Coils, The Penumbra Occlusion Device (POD) And Packing Coils Have Different Uses And Why They Are Valuable And Cost Effective For Different Lesions: Technical Tips For Optimizing
  Presenter(s):Sean P. Lyden, MD  
  View Slides in PDF      
4:55 PM - 5:00 PM

Power Point Presentation with Synched Audio
Caterpillar™ Embolic Plug (From Bard): How Does It Work: Advantages And Clinical Results
  Presenter(s):Andrew Holden, MBChB  
  View Slides in PDF      
5:01 PM - 5:06 PM How To Treat Type 1A Endoleaks With Ruby Coils: When Will They Work; When Will They Not: Technical Tips
  Presenter(s):Mazin Foteh, MD  
  View Slides in PDF      
5:07 PM - 5:12 PM How To Insert Large Vessel Embolization Devices (PODs) Through Low Profile Access
  Presenter(s):Frank R. Arko, MD  
  View Slides in PDF      
5:13 PM - 5:18 PM Floating Clot At The Carotid Bifurcation Is A Prime Indication For Flow Reversal Technology During Treatment Of Carotid Stenosis: How Can Flow Reversal Best Be Achieved In This Setting
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS / Juan C. Parodi, MD  
  View Slides in PDF      
5:19 PM - 5:30 PM Panel Discussion
5:30 PM - 5:30 PM End of Program F
END OF SESSION 59
 
SESSION 60 SCHEDULE
Thursday
SESSION 60: VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
x
8:00 AM - 8:04 AM Introduction To Veins At VEITH
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
8:05 AM - 8:10 AM AVF CEAP Revision 2020
  Presenter(s):Marc A. Passman, MD  
  View Slides in PDF      
8:11 AM - 8:16 AM CEAP, VCSS, HASTI: Their Significance And How To Utilize
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
  View Slides in PDF      
8:17 AM - 8:22 AM Physiology Of Venous Return
  Presenter(s):Brajesh K. Lal, MD  
  View Slides in PDF      
8:23 AM - 8:28 AM Status Of The Evidence For C2 Intervention
  Presenter(s):Peter Gloviczki, MD  
  View Slides in PDF      
8:29 AM - 8:34 AM An Algorithm To Predict Disease Severity In C2 Patients
  Presenter(s):Mikel Sadek, MD  
  View Slides in PDF      
8:35 AM - 8:40 AM Evidence Summary On The Pathophysiology Of Varicose Veins
  Presenter(s):Thomas W. Wakefield, MD  
  View Slides in PDF      
8:41 AM - 8:46 AM CVD: A Clinical Approach Algorithm
  Presenter(s):Seshadri Raju, MD  
  View Slides in PDF      
8:47 AM - 8:53 AM Non-Venous Causes Of The Swollen Extremity
  Presenter(s):Andrea T. Obi, MD  
  View Slides in PDF      
8:53 AM - 8:58 AM Quality Of Life Tools Reflect Disease Severity, But They Can Be Improved
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS  
  View Slides in PDF      
8:59 AM - 9:04 AM Panel Discussion
END OF SESSION 60
 
SESSION 61 SCHEDULE
Thursday
SESSION 61: VENOUS IMAGING AND BIOLOGY
Moderators:Raghu Kolluri, MD / Steve Elias, MD  
x
9:05 AM - 9:10 AM 1470mm Laser And Wound Care Trial
  Presenter(s):Lorena Grillo, MD  
  View Slides in PDF      
9:11 AM - 9:16 AM Are They Venous Ulcers
  Presenter(s):Raghu Kolluri, MD  
  View Slides in PDF      
9:17 AM - 9:22 AM Ambulatory Venous Pressure, Air Plethysmography, And The Role Of Calf Venous Pump In Chronic Venous Disease
  Presenter(s):Seshadri Raju, MD  
  View Slides in PDF      
9:23 AM - 9:28 AM Does Deep Venous Reflux Matter With Superficial Ablation
  Presenter(s):Peter Henke, MD  
  View Slides in PDF      
9:29 AM - 9:34 AM Non Contact Imaging For Superficial Disease: How Does It Help
  Presenter(s):Steve Elias, MD  
  View Slides in PDF      
9:35 AM - 9:40 AM Understanding Venous Physiology Helps Guide Therapy
  Presenter(s):Fedor Lurie, MD, PhD  
  View Slides in PDF      
9:41 AM - 9:46 AM Panel Discussion
END OF SESSION 61
 
SESSION 62 SCHEDULE
Thursday
SESSION 62: SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
x
9:47 AM - 9:52 AM Results Of Randomized Controlled Trial MOCCA Versus Cyanoacrylate
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS  
  View Slides in PDF      
9:53 AM - 9:58 AM “Choosing Wisely” Items For Chemical Or Thermal Ablation In The Treatment Of The Incompetent Saphenous Veins And Recurrence
  Presenter(s):Claudine M. Hamel-Desnos, MD  
  View Slides in PDF      
9:59 AM - 10:04 AM What Drugs Do I Recommend For Symptomatic Venous Disease
  Presenter(s):Jorge H. Ulloa, MD, FACS  
  View Slides in PDF      
10:05 AM - 10:10 AM Ablative Procedures And Cost Effectiveness
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS  
  View Slides in PDF      
10:11 AM - 10:16 AM SVT Treatment During Pregnancy: Treatment Choices
  Presenter(s):Ellen D. Dillavou, MD  
  View Slides in PDF      
10:17 AM - 10:22 AM Vein Histopathology: 5.5 Years After Cyanoacrylate Closure
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
  View Slides in PDF      
10:23 AM - 10:28 AM Saphenous Ablation On Anticoagulation: Is It Safe, Effective And Durable
  Presenter(s):Glenn Jacobowitz, MD  
  View Slides in PDF      
10:29 AM - 10:34 AM Panel Discussion
10:35 AM - 10:50 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 62
 
SESSION 63 SCHEDULE
Thursday
SESSION 63: THERMAL AND NON-THERMAL ABLATION – PART 1
x
10:50 AM - 10:55 AM Decision Making In Saphenous Ablation: What To Use When
  Presenter(s):Ellen D. Dillavou, MD  
  View Slides in PDF      
10:56 AM - 11:01 AM HIFU: Is It Ready For Prime Time
  Presenter(s):Mark S. Whiteley, MS, FRCS  
  View Slides in PDF      
11:02 AM - 11:07 AM Tips, Tricks And Limitations: HIFU
  Presenter(s):Mark S. Whiteley, MS, FRCS  
  View Slides in PDF      
11:08 AM - 11:13 AM Tips, Tricks And Limitations: Perforator Ablation
  Presenter(s):Steve Elias, MD  
  View Slides in PDF      
11:14 AM - 11:19 AM Tips, Tricks And Limitations: Varithena
  Presenter(s):Edward G. Mackay, MD  
  View Slides in PDF      
11:20 AM - 11:25 AM Tips, Tricks, And Limitations: Laser Truncal Ablation
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
  View Slides in PDF      
11:26 AM - 11:31 AM Panel Discussion
END OF SESSION 63
 
SESSION 64 SCHEDULE
Thursday
SESSION 64: THERMAL AND NON-THERMAL ABLATION – PART 2
x
11:32 AM - 11:37 AM Tips, Tricks, And Limitations: Liquid Sclerotherapy
  Presenter(s):Victor M. Canata, MD, PhD  
  View Slides in PDF      
11:38 AM - 11:43 AM Tips, Tricks And Limitations: Clarivein
  Presenter(s):Steve Elias, MD  
  View Slides in PDF      
11:44 AM - 11:49 AM Tips, Tricks And Limitations: VenaSeal
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS  
  View Slides in PDF      
11:50 AM - 11:55 AM Tips, Tricks And Limitations: Radiofrequency Ablation
  Presenter(s):Alan M. Dietzek, MD, RPVI, FACS  
  View Slides in PDF      
11:56 AM - 12:01 PM Tips, Tricks And Limitations: Brazilian Phlebectomy
  Presenter(s):Gutenberg A. Gurgel, MD, MSc  
  View Slides in PDF      
12:02 PM - 12:07 PM Tips, Tricks And Limitations: Phlebogrif
  Presenter(s):Lorena Grillo, MD  
  View Slides in PDF      
12:08 PM - 12:13 PM Safety And Efficacy Of Endovenous Ablations InOctogenarians, Nonagenarians, And Centenarians
  Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD  
  View Slides in PDF      
12:14 PM - 12:20 PM Panel Discussion
12:20 PM - 1:15 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 64
 
SESSION 65 SCHEDULE
Thursday
SESSION 65: SPIDER VEINS, TRUNCAL VEINS, TRIBUTARY VEINS, EXOTIC VEIN TREATMENT
x
1:15 PM - 1:20 PM Foam Therapies (PCF Versus PEM): When To Use And Does It Make A Difference
  Presenter(s):Edward G. Mackay, MD  
  View Slides in PDF      
1:21 PM - 1:26 PM Patient Preferences For Thermal Ablation Versus Non-Thermal, Non-Tumescent Varicose Vein Treatments: A Choice-Based Conjoint (CBS) Analysis
  Presenter(s):Peter J. Pappas, MD  
  View Slides in PDF      
1:27 PM - 1:32 PM Randomized Controlled Study Of EVLA And Foam In the SSV-Fovelass Study: 3-Year Results
  Presenter(s):Claudine M. Hamel-Desnos, MD  
  View Slides in PDF      
1:33 PM - 1:38 PM CLACS In Paraguay Results Of The Aesthetic Phlebology Trial
  Presenter(s):Victor M. Canata, MD, PhD  
  View Slides in PDF      
1:39 PM - 1:44 PM Superficial Ablation Outcomes (5 Years) In 13,000 Patients
  Presenter(s):Peter J. Pappas, MD  
  View Slides in PDF      
1:45 PM - 1:50 PM Labial Varices: Choices And How I Do It
  Presenter(s):Ellen D. Dillavou, MD  
  View Slides in PDF      
1:51 PM - 1:56 PM Which Saphenous Vein Recanalization Should Be Treated
  Presenter(s):Kathleen D. Gibson, MD  
  View Slides in PDF      
1:57 PM - 2:02 PM Is Combination Therapy Laser And Sclerotherapy More Efficacious For Telangiectatic Treatment
  Presenter(s):Gutenberg A. Gurgel, MD, MSc  
  View Slides in PDF      
2:03 PM - 2:08 PM Concomitant Versus Staged Tributary Treatment
  Presenter(s):Kathleen D. Gibson, MD  
  View Slides in PDF      
2:09 PM - 2:14 PM Panel Discussion
END OF SESSION 65
 
SESSION 66 SCHEDULE
Thursday
SESSION 66: VENOUS SOCIETAL AND GOVERNANCE
x
2:21 PM - 2:26 PM The Future Of Venous Reimbursement In A Non-Fee For Service Environment
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
  View Slides in PDF      
2:27 PM - 2:32 PM Can We Use The Data From VQI VVR To Advocate For Coverage Of Venous Procedures
  Presenter(s):Nicholas H. Osborne, MD, MS  
  View Slides in PDF      
2:33 PM - 3:38 PM Results Of Appropriateness Criteria (AVF) I
  Presenter(s):Kathleen J. Ozsvath, MD  
  View Slides in PDF      
2:39 PM - 2:44 PM Results Of Appropriateness Criteria (AVF) II
  Presenter(s):Kathleen J. Ozsvath, MD  
  View Slides in PDF      
2:45 PM - 2:50 PM Ground Zero On 9/11: What Did We Learn
  Presenter(s):Mark A. Adelman, MD  
  View Slides in PDF      
2:51 PM - 2:56 PM Focused Practice Designation – Venous Disease Treatment
  Presenter(s):Brajesh K. Lal, MD  
  View Slides in PDF      
2:57 PM - 3:02 PM From The AVF And SVS: EHIT Recommendations
  Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FAVLS  
  View Slides in PDF      
3:03 PM - 3:12 PM Panel Discussion
END OF SESSION 66
 
SESSION 67 SCHEDULE
Thursday
SESSION 67: MORE SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
x
3:13 PM - 3:18 PM Risk Factors For EHIT And Recanalization: An Analysis Of 10,000 Patients
  Presenter(s):Anil P. Hingorani, MD  
  View Slides in PDF      
3:19 PM - 3:24 PM Ablation Outcomes In Obese Patients
  Presenter(s):Peter J. Pappas, MD  
  View Slides in PDF      
3:25 PM - 3:30 PM Venolymphatic Edema And Its Treatment Options Raghu Kolluri, MD
  Presenter(s):Raghu Kolluri, MD  
  View Slides in PDF      
3:31 PM - 3:36 PM Radiofrequency Ablation Increases The Incidence Of Endothermal Heat Induced Thrombosis
  Presenter(s):Anil P. Hingorani, MD  
  View Slides in PDF      
3:37 PM - 3:42 PM Varithena® VLU Registry: The Effects Of Polidocanol Endovenous Microfoam On Wound Healing And Recurrence
  Presenter(s):Raghu Kolluri, MD  
  View Slides in PDF      
3:43 PM - 3:48 PM Saphenous Incompetence With Post-Thrombotic Deep Veins
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
  View Slides in PDF      
3:49 PM - 3:54 PM European College Of Phlebology Guideline for Truncal Ablation
  Presenter(s):Kursat A. Bozkurt, MD  
  View Slides in PDF      
3:55 PM - 4:00 PM Varicose Veins Among Klippel Trenaunay Syndrome: What You Should Know About
  Presenter(s):Byung-Boong Lee, MD  
  View Slides in PDF      
4:01 PM - 4:10 PM Panel Discussion
4:10 PM - 4:25 PM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 67
 
SESSION 68 SCHEDULE
Thursday
SESSION 68: VENOUS CLINICAL TRIALS; LYMPHATIC AND VEIN TREATMENT STRATEGIES
x
4:25 PM - 4:30 PM What Articles Are JVS-VL Looking For and How Can You Write A Paper That Will Be Accepted And Published
  Presenter(s):Peter Gloviczki, MD  
  View Slides in PDF      
4:31 PM - 4:36 PM Unilateral, Bilateral, Staged Endovenous Ablation – VQI Data
  Presenter(s):Nicholas H. Osborne, MD, MS  
  View Slides in PDF      
4:37 PM - 4:42 PM Is Saphenous Vein Stripping A Cost-Effective Treatment
  Presenter(s):Lourdes Reina, MD  
  View Slides in PDF      
4:43 PM - 4:48 PM The Recalcitrant Ulcer: Our 52-Week Analysis
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
  View Slides in PDF      
4:49 PM - 4:54 PM Correlation Amongst Transabdominal/Transvaginal Duplex Versus Venography For Pelvic Venous Insufficiency And Leg Varicosities
  Presenter(s):Lourdes Reina, MD  
  View Slides in PDF      
4:55 PM - 5:00 PM Treating Low And Moderate Severity Venous Disease Is Beneficial – Data From The VQI VVR
  Presenter(s):Nicholas H. Osborne, MD, MS  
  View Slides in PDF      
5:01 PM - 5:06 PM What Venous Trials Do We Need
  Presenter(s):Mark H. Meissner, MD  
  View Slides in PDF      
5:07 PM - 5:12 PM Panel Discussion
END OF SESSION 68
 
SESSION 69 SCHEDULE
Thursday
SESSION 69: LIPEDEMA, LYMPHEDEMA, PHLEBOLYMPHEDEMA
x
5:13 PM - 5:18 PM Diagnosis Of Lipedema And Treatment
  Presenter(s):Steven M. Dean, DO  
  View Slides in PDF      
5:19 PM - 5:24 PM Overview Of Lymphatic Anatomy, Physiology And Imaging Techniques
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
  View Slides in PDF      
5:25 PM - 5:30 PM Phlebolymphedema: Hallmark Of Combined Insufficiency Of Venous-Lymphatic System
  Presenter(s):Byung-Boong Lee, MD  
  View Slides in PDF      
5:31 PM - 5:36 PM Clinical Characteristics Of Lower Extremity Lymphedema
  Presenter(s):Steven M. Dean, DO  
  View Slides in PDF      
5:37 PM - 5:42 PM Advanced Pneumatic Compression: Continued Improvement In Quality Of Life
  Presenter(s):Thomas S. Maldonado, MD  
  View Slides in PDF      
5:43 PM - 5:50 PM Panel Discussion
5:50 PM - 5:50 PM End of Program G
END OF SESSION 69
 
SESSION 70 SCHEDULE
Thursday
SESSION 70: STROKE 2021 INCLUDING COVID
x
7:45 AM - 7:50 AM Introduction
  Presenter(s):Allan L. Brook, MD  
7:51 AM - 8:01 AM Lessons Learned On Patient Selection For Acute Stroke Treatment
  Presenter(s):Michael D. Hill, MD  
  View Slides in PDF      
8:02 AM - 8:12 AM Innovative And Novel Stroke Therapies That Are In The Pipeline
  Presenter(s):Michael D. Hill, MD  
  View Slides in PDF      
8:13 AM - 8:23 AM COVID-19 Overview Of What Happened
  Presenter(s):Seon-Kyu Lee, MD, PhD  
  View Slides in PDF      
8:24 AM - 8:34 AM Long -Term Effects Of Stroke: COVID-19 Is Here To Stay
  Presenter(s):Reade A. De Leacy, MBBS  
  View Slides in PDF      
8:35 AM - 8:45 AM How CSC/Organized Medicine Helped Prepare Us For The COVID Onslaught
  Presenter(s):Ansaar T. Rai, MD  
  View Slides in PDF      
8:45 AM - 8:50 AM Collateral Physiologic Flow: Our Friends And Our Foes
  Presenter(s):Allan L. Brook, MD  
  View Slides in PDF      
8:50 AM - 9:00 AM Panel Discussion
9:00 AM - 9:10 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 70
 
SESSION 71 SCHEDULE
Thursday
SESSION 71: CAROTIDS AND REVASCULARIZATION
x
9:11 AM - 9:21 AM

Power Point Presentation with Synched Audio
Carotid Revascularization: Observations Of Change Over The Course Of A Career
  Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD  
9:22 AM - 9:33 AM Medical Management Of Carotid Disease
  Presenter(s):Michael D. Hill, MD  
  View Slides in PDF      
9:33 AM - 9:43 AM TCAR: Technical Pearls: Why It’s The Latest Trending Vascular Procedure
  Presenter(s):Mahmoud B. Malas, MD, MHS  
  View Slides in PDF      
9:44 AM - 9:54 AM TCAR: Why Not Just Do An Endarterectomy
  Presenter(s):Marc L. Schermerhorn, MD  
  View Slides in PDF      
9:55 AM - 10:05 AM Pooled Analysis With Greater Power From The CREST And ACT I Trials With Asymptomatic Patients Clarifies The CREST Conclusion: Sex Makes No Difference Between CEA And CAS While Oldest Age Group Demonstrates Worse Results With CAS
  Presenter(s):Jon S. Matsumura, MD / Bret M. Hanlon, PhD  
  View Slides in PDF      
10:06 AM - 10:30 AM Panel Discussion
10:30 AM - 10:40 AM Break - Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 71
 
SESSION 72 SCHEDULE
Thursday
SESSION 72: INTRACRANIAL HEMORRHAGE
x
10:40 AM - 10:50 AM Hemicraniectomy: Why It Is Not A Lost Art, And Benefits
  Presenter(s):Adam S. Arthur, MD  
  View Slides in PDF      
10:51 AM - 11:01 AM Devices Are The Next Generation Of Aneurysm Treatment Or Is It Prevention
  Presenter(s):Ajay K. Wakhloo, MD, PhD, FAHA  
  View Slides in PDF      
11:02 AM - 12:00 PM Intrasaccular Devices: Overview And Indications
  Presenter(s):David J. Altschul, MD  
  View Slides in PDF      
11:13 AM - 11:23 PM Unruptured Aneurysms: Why Do We Treat These
  Presenter(s):James Milburn, MD  
  View Slides in PDF      
11:24 AM - 11:34 AM Intracranial Hemorrhage: Open Or Closed Treatment-Decision Tree
  Presenter(s):Brian L. Hoh, MD  
  View Slides in PDF      
11:35 AM - 11:45 AM Sub-Dural Hemorrhage Endovascular Therapy: Trials And Tribulations
  Presenter(s):Adam S. Arthur, MD  
  View Slides in PDF      
11:46 AM - 11:56 AM Cerebrovascular Vascular Malformation Classification And Management Decisions
  Presenter(s):Wayne F. Yakes, MD  
  View Slides in PDF      
11:57 AM - 12:10 PM Panel Discussion
12:10 PM - 12:10 PM End of Program H
12:11 PM - 1:00 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 72
 
SESSION 73 SCHEDULE
Friday
SESSION 73: PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS
x
7:00 AM - 7:05 AM A Multidisciplinary Approach To Prevent SCI During Endovascular TAAA Repairs
  Presenter(s):Patrick W. Kelly, MD  
  View Slides in PDF      
7:06 AM - 7:11 AM Strategies To Minimize Paraplegia After TAAA Repairs: How A Biomarker Can Help
  Presenter(s):Bijan Modarai, PhD, FRCS  
  View Slides in PDF      
7:12 AM - 7:17 AM

Power Point Presentation with Synched Audio
Cerebrospinal Fluid (CSF) Drainage (To Decrease SCI) Is Not A Benign Procedure: Why: When Not And When To Use It
  Presenter(s):Gustavo S. Oderich, MD, FACS  
  View Slides in PDF      
7:18 AM - 7:23 AM SCI Is More Severe And Resolves Less When Routine CSF Drainage Is Used With TAAA Repairs: When Should It Be Used Selectively And With What Precautions
  Presenter(s):Adam Beck, MD  
  View Slides in PDF      
7:24 AM - 7:29 AM Near Infrared Spectrometry (NIRS) Monitoring Is Helpful In Decreasing SCI With TAAA Repairs: How To Do It: Why Is There Controversy
  Presenter(s):Carlos H. Timaran, MD  
  View Slides in PDF      
7:30 AM - 7:35 AM Current Strategies To Minimize SCI With TAAA Repairs, Endo And Open: Status Of Intercostal Embolization As Preconditioning To Prevent Ischemia (MIS2ACE): Status Of PAPA-ARTIS RCT
  Presenter(s):Christian D. Etz, MD, PhD  
  View Slides in PDF      
7:36 AM - 7:41 AM Clinical Experience With Intercostal Coil Embolization (MIS2ACE) To Prevent SCI With Endovascular TAAA Repair
  Presenter(s):Daniela Branzan, MD / Christian D. Etz, MD, PhD / Andrej Schmidt, MD  
  View Slides in PDF      
7:42 AM - 7:50 AM Panel Discussion
END OF SESSION 73
 
SESSION 74 SCHEDULE
Friday
SESSION 74: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION (TCAR)
x
MESH COVERED STENTS
7:50 AM - 7:55 AM

Power Point Presentation with Synched Audio
Long-Term Results Of Micromesh Stents Show Their Value In Carotid Artery Stenting (CAS): Are There Limitations: Do The Differences In The 3 Micromesh Stents Matter
  Presenter(s):Max Amor, MD  
7:56 AM - 8:01 AM Advantages And Limitations Of Mesh Covered Stents In CAS: Are They Really Better
  Presenter(s):Laura Capoccia, MD, PhD  
  View Slides in PDF      
8:02 AM - 8:07 AM

Power Point Presentation with Synched Audio
7-Year Experience With Micromesh Stents For CAS: Are There Downsides (Thrombosis Or ISR): Technical Tips To Optimize Their Results
  Presenter(s):Stefan Mueller-Huelsbeck, MD  
  View Slides in PDF      
8:08 AM - 8:13 AM New Multicenter Data Showing The Long-Term Value Of The C-Guard Micronet Mesh Covered Stent For CAS In High Risk Carotid Lesions (Thrombotic, Calcified And Symptomatic) From The Flow-Guard And Other Trials
  Presenter(s):Piotr Musialek, MD, DPhil / D. Christopher Metzger, MD   
  View Slides in PDF      
TCAR RELATED TOPICS
8:14 AM - 8:19 AM TCAR Versus CEA (Carotid Endarterectomy): A Propensity Matched SVS VQI Study: 1-Year Results Show Equal Stroke/Death Rates And Decreased Cranial Nerve Injuries With TCAR: Findings Also Confirmed By A Meta-Analysis
  Presenter(s):Mahmoud B. Malas, MD, MHS / Marc L. Schermerhorn, MD  
  View Slides in PDF      
8:20 AM - 8:25 AM TCAR Versus Transfemoral CAS (TFCAS): A Propensity Matched SVS VQI Study Shows That TCAR Has Lower Stroke And Death Rates Than TFCAS
  Presenter(s):Marc L. Schermerhorn, MD / Mahmoud B. Malas, MD, MHS / Vikram S. Kashyap, MD  
  View Slides in PDF      
8:26 AM - 8:31 AM Why I Am Uncertain That TCAR Will Have Better Outcomes Than TFCAS: What Does The CREST 2 Registry Show
  Presenter(s):Thomas G. Brott, MD / William A. Gray, MD / 
  View Slides in PDF      
8:32 AM - 8:37 AM DEBATE: For TFCAS Reversal Or Cessation Of Flow With The Gore Or MoMA Device Cerebral Embolic Protection Is No Better Than Filter Protection: Why Is This So
  Presenter(s):Marc L. Schermerhorn, MD  
  View Slides in PDF      
8:38 AM - 8:43 AM DEBATE: Not So: In Some Specific Circumstances Reversal Or Cessation Of Flow Protection During TFCAS Is Better And Safer Than Filter Protection
  Presenter(s):William A. Gray, MD / 
  View Slides in PDF      
8:44 AM - 8:49 AM Based On Data To Date When Should TCAR Replace CEA And When Should It Not: A Balanced View
  Presenter(s):Vikram S. Kashyap, MD  
  View Slides in PDF      
8:50 AM - 8:55 AM TCAR Seems Better Than TFCAS And Equal To CEA: It Has A Bright Future: What Are Its Drawbacks
  Presenter(s):Wesley S. Moore, MD  
  View Slides in PDF      
8:56 AM - 9:04 AM Panel Discussion
9:04 AM - 9:17 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 74
 
SESSION 75 SCHEDULE
Friday
SESSION 75: MORE CAROTID HOT TOPICS RELATED TO TCAR, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS AND COGNITIVE FUNCTION
x
9:17 AM - 9:22 AM TCAR Is Safe In Recently Symptomatic Patients And Those With Contralateral Carotid Occlusions: Why It Should Be The Procedure Of Choice In Those Conditions
  Presenter(s):Peter A. Schneider, MD  
  View Slides in PDF      
9:23 AM - 9:28 AM DEBATE: TCAR Is Not Hard To Learn: Results Are Unrelated To Operator Experience In ROADSTER 2 Trial
  Presenter(s):Vikram S. Kashyap, MD  
  View Slides in PDF      
9:29 AM - 9:34 AM DEBATE: Not So: TCAR Has A Steeper Learning Curve Than Commonly Thought: Some Precautions To Prevent Adverse Events
  Presenter(s):Michael B. Silva, Jr., MD / Charles Thang, MD  
  View Slides in PDF      
9:35 AM - 9:40 AM Learning And Optimizing The TCAR Procedure
  Presenter(s):Edward Y. Woo, MD / Steven D. Abramowitz, MD  
  View Slides in PDF      
9:41 AM - 9:46 AM Complications Of TCAR: How To Avoid Them And Fix Those That Occur
  Presenter(s):Thomas S. Maldonado, MD  
  View Slides in PDF      
9:47 AM - 9:52 AM Adjunctive EEG Can Help With TCAR And Decrease The Stroke Rate: When And How
  Presenter(s):Todd R. Vogel, MD, MPH  
  View Slides in PDF      
9:53 AM - 9:58 AM Mini-Incision CEA Is Better And Less Costly Than TCAR
  Presenter(s):Enrico Ascher, MD  
  View Slides in PDF      
9:59 AM - 10:04 AM TCAR Can Be Performed Under Local Anesthesia With Outcomes Equal To TCAR Under General Anesthesia: From A VQI Study: How To Do It Safely
  Presenter(s):Dipankar Mukherjee, MD  
  View Slides in PDF      
SIGNIFICANCE OF SMALL DW MRI DEFECTS AFTER CEA/CAS
10:05 AM - 10:10 AM DEBATE: How Size And Number Of Silent Brain Infarcts (DW MRI Defects) After CEA/CAS Affect Cognitive Changes: They Really Do Matter
  Presenter(s):Wei Zhou, MD  
  View Slides in PDF      
10:11 AM - 10:16 AM DEBATE: Silent DWI MRI Brain Lesions (Small Infarcts) After CEA/CAS Don’t Matter
  Presenter(s):Thomas G. Brott, MD  
  View Slides in PDF      
10:17 AM - 10:22 AM

Power Point Presentation with Synched Audio
Why Asymptomatic Carotid Stenosis (ACS) Is Associated With Impaired Cognitive Function And Silent Infarcts: However, CEA And CAS For ACS Cause More Cognitive Impairment Than They Prevent
  Presenter(s):J. David Spence, MD  
  View Slides in PDF      
10:23 AM - 10:30 AM Panel Discussion
END OF SESSION 75
 
SESSION 76 SCHEDULE
Friday
SESSION 76: MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, MESH COVERED STENTS, MINI-INCISION CEA, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
x
10:30 AM - 10:35 AM Comparative Cost Effectiveness: TCAR Versus CEA Versus TFCAS
  Presenter(s):Mohammad H. Eslami, MD, MPH  
  View Slides in PDF      
10:36 AM - 10:41 AM

Power Point Presentation with Synched Audio
Value Of Lithotripsy (Shockwave) For CAS In Heavily Calcified Lesions: How To Do It Safely And Technical Tips: Limitations And Precautions
  Presenter(s):Max Amor, MD  
10:42 AM - 10:47 AM

Power Point Presentation with Synched Audio
Results From A Multicenter Italian Study Of The C-Guard Micromesh Stent For CAS: Advantages And Complications
  Presenter(s):Gianmarco de Donato, MD / Carlo Setacci, MD / Francesco Speziale, MD / Wassim Mansour, MD / Pasqualino Sirignano, MD  
  View Slides in PDF      
10:48 AM - 10:53 AM OCT Proves CAS Is Rendered Safer Because Emboli Are Decreased By Mesh Covered Stents: The Evidence
  Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD  
  View Slides in PDF      
10:54 AM - 10:59 AM Transcranial Doppler (TCD) Hits During TCAR: When Do They Occur And What Is Their Significance
  Presenter(s):Cynthia K. Shortell, MD  
  View Slides in PDF      
11:00 AM - 11:05 AM TCAR Versus Minimal Incision CEA: Cost Effectiveness, Advantages And Limitations Of Both
  Presenter(s):Robert M. Proczka, MD, PhD  
  View Slides in PDF      
11:06 AM - 11:12 AM Panel Discussion
TIMING OF CAROTID INTERVENTIONS AFTER SYMPTOM ONSET
11:12 AM - 11:17 AM Optimal Timing Of Carotid Revascularization (CEA, TFCAS, TCAR) After Symptom Onset: Within 48 Hours Risk Is Increased For All Procedures; After 48 Hours Risk Is Less With CEA And TCAR Than With TFCAS: Based On Large National Database Study
  Presenter(s):Mahmoud B. Malas, MD, MHS  
  View Slides in PDF      
11:18 AM - 11:23 AM DEBATE: It’s Reasonable To Perform CEA Within 48 Hours After A Stroke’s Symptoms Start: Under What Conditions And What Precautions Should Be Taken
  Presenter(s):R. Clement Darling III, MD  
  View Slides in PDF      
11:24 AM - 11:29 AM DEBATE: Patients With Moderate To Severe Strokes Do Poorly With Both CEA And CAS Done Within 48 Hours Of Symptom Onset: Both Procedures Should Be Avoided During This Period: How Long Should One Wait
  Presenter(s):Hernan A. Bazan, MD, DFSVS, FACS  
  View Slides in PDF      
11:30 AM - 11:35 AM

Power Point Presentation with Synched Audio
What Is The Best Medical Treatment For Patients With Carotid Stenosis (Asymptomatic And Asymptomatic): Can High Risk Plaques Be Made Low Risk And Can They Be Made Smaller: Are Some Plaques Resistant To Medical Treatment And Why
  Presenter(s):J. David Spence, MD  
  View Slides in PDF      
11:36 AM - 11:41 AM Technical Tips And Maneuvers To Make Treatment Of High Carotid Lesions Safe And Relatively Simple
  Presenter(s):Richard J. Powell, MD  
  View Slides in PDF      
11:42 AM - 11:47 AM

Power Point Presentation with Synched Audio
Getting Non-Compliant Carotid Patients To Comply With Best Medical Treatment By Showing Them Their Duplex Scans And Pictures Of Hemorrhagic And Ulcerated Plaques
  Presenter(s):J. David Spence, MD  
  View Slides in PDF      
11:48 AM - 0:00 AM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 76
 
SESSION 77 SCHEDULE
Friday
SESSION 77: MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTs; NEW INFORMATION ON TREATMENT OF TANDEM LESIONS, CAROTID ANEURYSMS AND STROKES DURING INTERVENTION
x
1:00 PM - 1:05 PM Optimal Management Of Extracranial Carotid Aneurysms In 2021: When Open; When Endo: Technical Tips And Results
  Presenter(s):Samuel R. Money, MD, MBA  
  View Slides in PDF      
UPDATE ON CAROTID RCTs
1:06 PM - 1:11 PM Update On ACST 2: CEA Versus CAS For ACS: What Is It Telling Us And When Will We Have All The Answers
  Presenter(s):Richard Bulbulia, MA, MD, FRCS / Alison Halliday, MS, FRCS  
  View Slides in PDF      
1:12 PM - 1:17 PM

Power Point Presentation with Synched Audio
Initial Results Of ACST 2 Trial
  Presenter(s):Alison Halliday, MS, FRCS / Richard Bulbulia, MA, MD, FRCS  
  View Slides in PDF      
1:18 PM - 1:23 PM

Power Point Presentation with Synched Audio
Not So Fast! ACST 2 Has Flaws That Invalidate Its Conclusions: What Are They
  Presenter(s):J. David Spence, MD  
  View Slides in PDF      
1:24 PM - 1:29 PM

Power Point Presentation with Synched Audio
Update On SPACE 2: CEA Versus Best Medical Treatment (BMT); CAS Versus BMT For ACS: Updated And Interesting Findings From A Stopped RCT
  Presenter(s):Hans-Henning Eckstein, MD, PhD  
  View Slides in PDF      
1:30 PM - 1:35 PM Update On CREST 2: CEA Versus BMT And CAS Versus BMT For ACS: Findings To Date And When Will We Have Final Results
  Presenter(s):Brajesh K. Lal, MD / Thomas G. Brott, MD  
  View Slides in PDF      
1:36 PM - 1:41 PM Why Is BMT With Clopidogrel Different In The Arms Of CREST and CREST 2 And Why This Difference Could Invalidate The RCTs Results
  Presenter(s):Timothy M. Sullivan, MD  
  View Slides in PDF      
TANDEM CAROTID LESIONS
1:42 PM - 1:47 PM Tandem Lesions At The Carotid Bifurcation Plus The Common Carotid Or Innominate Arteries: Stroke And Mortality Risks Are Higher Than For Simple Bifurcation Lesions: How Best To Treat: Endo, Open, Staged, Hybrid
  Presenter(s):W. Darrin Clouse, MD  
  View Slides in PDF      
1:48 PM - 1:53 PM CEA And Retrograde Stenting Of A Tandem Proximal Lesion: Technical Tips To Make It Safe And Effective
  Presenter(s):Christopher J. Smolock, MD  
  View Slides in PDF      
1:53 PM - 2:02 PM Panel Discussion
END OF SESSION 77
 
SESSION 78 SCHEDULE
Friday
SESSION 78: MORE HOT CAROTID TOPICS: TREATMENT IN 2021 OF BIG CAROTID BODY TUMORS, OPTIMAL PLATELET AND PROTAMINE STRATEGIES; BENIGNANCY OF ACS
x
2:02 PM - 2:07 PM Technical Tips For Treating Large Shamblin III Carotid Body Tumors Safely; From An Ecuadorian Team Which Treats Many
  Presenter(s):Oscar L. Ojeda, MD, FACS  
  View Slides in PDF      
2:08 PM - 2:13 PM

Power Point Presentation with Synched Audio
Value Of Protamine Use During CEA: How Should It Be Used And With What Precautions
  Presenter(s):David H. Stone, MD  
  View Slides in PDF      
2:14 PM - 2:19 PM CEA Can Be Performed Safely And Optimally Under General Anesthesia And Without Completion Duplex Or Angio Control: What Is Required To Do So And Are There Downsides To Duplex Or Angio Controls
  Presenter(s):Ali F. AbuRahma, MD  
  View Slides in PDF      
2:20 PM - 2:25 PM Are Symptomatic And Asymptomatic Carotid Stenosis Really 2 Different Diseases As Some Suggest
  Presenter(s):Thomas G. Brott, MD  
  View Slides in PDF      
2:26 PM - 2:31 PM Risks And Causes Of Non-Ipsilateral Stroke Complicating CEA
  Presenter(s):W. Darrin Clouse, MD / Mark Conrad, MD, MMSc  
  View Slides in PDF      
2:32 PM - 2:37 PM Unnecessary Redundant Testing/Imaging Prior To CEA: What Is The Reason For This Needless Addition To Health Care Costs
  Presenter(s):Reese A. Wain, MD  
  View Slides in PDF      
2:38 PM - 2:43 PM DEBATE: CAS Is The Best Treatment For Young Patients With A High Grade Asymptomatic Carotid Stenosis (ACS)
  Presenter(s):William A. Gray, MD / 
  View Slides in PDF      
2:44 PM - 2:49 PM

Power Point Presentation with Synched Audio
DEBATE: Not So: Young Patients With A High Grade ACS Should Not Be Treated By CAS Or CEA
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
  View Slides in PDF      
2:50 PM - 3:12 PM Panel Discussion
3:12 PM - 3:22 PM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 78
 
SESSION 79 SCHEDULE
Friday
SESSION 79: NEW OR UPDATED CONCEPTS FOR ENDOVASCULAR TREATMENTS
x
3:22 PM - 3:27 PM

Power Point Presentation with Synched Audio
Clinical Judgment Is Required In The Application Of Evidence Based Medicine: RCTs Can Have Flaws Leading To Misleading Conclusions
  Presenter(s):J. David Spence, MD  
  View Slides in PDF      
3:28 PM - 3:33 PM How Should Left Subclavian Artery Stenosis Be Treated In Patients Before Coronary Artery Bypass: Stent Versus Carotid Subclavian Bypass Versus Ignore But Don’t Use The Left Internal Mammary Artery
  Presenter(s):Jennifer L. Perri, MD, MBA  
  View Slides in PDF      
3:34 PM - 3:39 PM Progress In Open And Endovascular Treatment For Erectile Dysfunction: Diagnosis And Treatment Of Cavernous Leak And Other Pathology: A New Horizon
  Presenter(s):Eric Allaire, MD, PhD  
  View Slides in PDF      
3:40 PM - 3:45 PM Embolic Treatment Of Hemorrhoids: How To Do It And How Well Does It Work
  Presenter(s):Gloria Salazar, MD  
  View Slides in PDF      
3:46 PM - 3:51 PM Using Machine Learning To Improve Stroke Prediction In Carotid Stenosis Patients
  Presenter(s):Mathew D. Wooster, MD, MBA / Ravi K. Veeraswamy, MD  
  View Slides in PDF      
3:52 PM - 3:57 PM Transfemoral Transcaval Liver Biopsy: A Better Way To Do It
  Presenter(s):Jacob Cynamon, MD, FACR, FSIR  
  View Slides in PDF      
3:58 PM - 4:04 PM Panel Discussion
END OF SESSION 79
 
SESSION 80 SCHEDULE
Friday
SESSION 80: NEW DEVELOPMENTS IN PERCUTANEOUS ACCESS CLOSURE, ENDOVASCULAR SUTURING AND WOUND CARE
x
4:04 PM - 4:09 PM

Power Point Presentation with Synched Audio
Update On Large Bore Percutaneous Access Closure Devices: Key New Devices And Developments: How To Prevent Failure And Complications
  Presenter(s):Zvonimir Krajcer, MD, FACC  
  View Slides in PDF      
4:10 PM - 4:15 PM

Power Point Presentation with Synched Audio
Endovascular Suturing Devices At The Tip Of An 8-9 French Catheter To Close Large Bore Sheath Access From Inside: The NovelRad Device: How Does It Work And Present Status
  Presenter(s):Elchanan Bruckheimer, MBBS  
  View Slides in PDF      
PROGRESS IN WOUND CARE
4:16 PM - 4:21 PM Optimal Treatment For Groin Infection After Prosthetic Bypasses From The Common Femoral Artery: How To Save The Graft And The Leg
  Presenter(s):Hosam F. El Sayed, MD  
  View Slides in PDF      
4:22 PM - 4:27 PM New Developments In The Treatment Of Mixed Arterial And Venous Wounds And Ulcers
  Presenter(s):Katherine A. Gallagher, MD  
  View Slides in PDF      
4:28 PM - 4:33 PM Value Of A Wound Care Center To A Vascular Practice: Who Should Staff It And How To Make It Revenue Positive
  Presenter(s):Venita Chandra, MD  
  View Slides in PDF      
4:34 PM - 4:39 PM

Power Point Presentation with Synched Audio
Best Treatment Strategies For Complex Infected Groin Wounds After Vascular Surgery: When To Do What: Wide Debridement, Antibiotics, Muscle Flap Reconstruction Or Graft Removal
  Presenter(s):Jan-Willem Elshof, MD  
  View Slides in PDF      
4:40 PM - 4:50 PM Panel Discussion
4:50 PM - 4:50 PM End of Program I
END OF SESSION 80
 
SESSION 81 SCHEDULE
Friday
SESSION 81: POPLITEAL DISEASE TOPICS RELATED TO NEW GUIDELINES, ANEURYSM TREATMENT (PRIMARY AND REDO), ENTRAPMENTS AND ATHERECTOMY FOR OCCLUSIVE LESIONS
x
POPLITEAL ANEURYSMS AND THEIR BEST CURRENT TREATMENTS
7:20 AM - 7:00 AM High Points Of New SVS Guidelines For The Treatment Of Popliteal Aneurysms: Roles Of Endo And Open Repairs
  Presenter(s):Patrick J. Geraghty, MD / Alik Farber, MD, MBA  
  View Slides in PDF      
7:26 AM - 7:31 AM

Power Point Presentation with Synched Audio
DEBATE: Endovascular Repair Is The Best Option For Most Popliteal Aneurysms Requiring Repair: Recent Progress In The Procedure: When Is Open Repair Indicated
  Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS  
  View Slides in PDF      
7:32 AM - 7:37 AM DEBATE: Open Repair With Prosthetic Bypass Graft Is Better Than Endovascular Treatment For Popliteal Aneurysms Requiring Repair
  Presenter(s):Laurent Chiche, MD, FEBVS  
  View Slides in PDF      
7:38 AM - 7:43 AM Update On Optimal Treatment For Popliteal Aneurysms: When Observation; When Endo Repair; When Open Repair And How
  Presenter(s):Fred A. Weaver, MD, MMM  
  View Slides in PDF      
7:44 AM - 7:49 AM What Are Complex Popliteal Aneurysms And How Should They Be Fixed: When Endo; When Open
  Presenter(s):Jacques Busquet, MD  
  View Slides in PDF      
7:50 AM - 7:56 AM Panel Discussion
POPLITEAL ENTRAPMENTS
7:56 AM - 8:01 AM What’s New In The Treatment Of Popliteal Entrapments
  Presenter(s):Niten Singh, MD  
  View Slides in PDF      
POPLITEAL ARTERY INJURY
8:02 AM - 8:07 AM Surgical Approach And Graft Usage For Popliteal Artery Injury From Posterior Knee Dislocation
  Presenter(s):Charles J. Fox, MD, FACS  
  View Slides in PDF      
POPLITEAL ARTERY ATHERECTOMY
8:08 AM - 8:13 AM

Power Point Presentation with Synched Audio
Value Of Orbital Atherectomy For Popliteal Artery Occlusive Lesions: Indications, Results, Precaution
  Presenter(s):Konstantinos P. Donas, MD  
  View Slides in PDF      
8:14 AM - 8:20 AM Panel Discussion
END OF SESSION 81
 
SESSION 82 SCHEDULE
Friday
SESSION 82: NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) INFECTIONS
x
8:20 AM - 8:25 AM Update On Deep Vein Use For Arterial Procedures: The NAIS Operation For Infections: Recent Technical Improvements
  Presenter(s):Patrick A. Stone, MD  
  View Slides in PDF      
TREATMENT OF MYCOTIC ANEURYSMS
8:26 AM - 8:31 AM Optimal Treatment Of Mycotic AAAs In 2021: Value Of And Precautions With EVAR: Is It Ever A Stand-Alone Treatment
  Presenter(s):Timur P. Sarac, MD  
  View Slides in PDF      
8:32 AM - 8:37 AM Rifampin Soaked Endografts To Treat Mycotic AAAs: How To Prepare Them And When To Use Them: Are They Stand-Alone Treatment Or Do They Need Adjunctive Techniques
  Presenter(s):Guillermo A. Escobar, MD  
  View Slides in PDF      
8:38 AM - 8:43 AM Why Open Repair Is The Best Treatment For Mycotic AAAs: Is EVAR Ever Of Value
  Presenter(s):Yamume Tshomba, MD  
  View Slides in PDF      
8:44 AM - 8:49 AM Best Treatment For Mycotic Aortic Aneurysms In The Thorax And Abdomen Based On Long-Term Results
  Presenter(s):Samy S. Nitecki, MD  
  View Slides in PDF      
TREATMENT OF AORTIC AND ARTERIAL GRAFT AND ENDOGRAFT INFECTIONS
8:50 AM - 8:55 AM Infected Endografts After EVAR: Etiological Factors, Diagnosis, Treatment, Outcomes
  Presenter(s):Mohammad H. Eslami, MD, MPH  
  View Slides in PDF      
8:56 AM - 9:01 AM Optimal Techniques For Treating Aorto-Iliac Graft And Endograft Infections In 2021
  Presenter(s):Anders Wanhainen, MD, PhD  
  View Slides in PDF      
9:02 AM - 9:07 AM

Power Point Presentation with Synched Audio
Semi-Conservative Therapy May Be Best For Some Aortic Graft Infections: What Is It And When Will Saving All Or Part Of An Infected Graft Work
  Presenter(s):Zoran Rancic, MD, PhD, EMBA HSG  
  View Slides in PDF      
9:08 AM - 9:13 AM Open Repair Of Suprarenal Aortic Graft Infections: Technical Tips And Long-Term Results
  Presenter(s):Thomas C. Bower, MD / Manju Kalra, MBBS  
  View Slides in PDF      
9:14 AM - 9:24 AM Panel Discussion
9:24 AM - 9:52 AM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 82
 
SESSION 83 SCHEDULE
Friday
SESSION 83: PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS WITH LESS RADIATION EXPOSURE OR CONTRAST TOXICITY
x
VASCULAR HOLOGRAPHY
9:52 AM - 9:57 AM How Will The Microsoft Hololens Look Through Patients’ Bodies And Facilitate Endovascular Interventions: The ARCUS System Of Augmented Reality And Its Value In Vascular Surgery
  Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS  
  View Slides in PDF      
9:58 AM - 10:03 AM

Power Point Presentation with Synched Audio
Real View Holographic Imaging: How Will It Help In Endovascular Treatments: Is It Available In The US
  Presenter(s):Elchanan Bruckheimer, MBBS  
  View Slides in PDF      
10:04 AM - 10:09 AM

Power Point Presentation with Synched Audio
Holographic Guidance Of Endovascular Procedures: What Is Possible And What Is Not
  Presenter(s):Claude Mialhe, MD  
  View Slides in PDF      
DUPLEX AND INTRAVASCULAR ULTRASOUND
10:10 AM - 10:15 AM Duplex Ultrasound Guidance: How, Where And When Can It Replace Fluoroscopy For Endovascular Procedures: Advantages, Limitations, And Why Its Use Is Increasing
  Presenter(s):Enrico Ascher, MD / Natalie A. Marks, MD, RPVI, RVT, FSVM  
  View Slides in PDF      
IMPROVED IMAGING
10:16 AM - 10:21 AM Dual Fluoroscopy With Live Image Digital Zooming: How Does It Work And Why Does It Decrease Radiation During Complex AAA Repairs: What Is Its Cost
  Presenter(s):Carlos H. Timaran, MD  
  View Slides in PDF      
10:22 AM - 10:27 AM Cydar Medical System’s Evolution To Facilitate Fusion With All Digital Fluoroscopes: How The System Uses AI To Improve EVAR Planning, Guidance And Deployment
  Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS  
  View Slides in PDF      
10:28 AM - 10:33 AM The Cydar System Deformation Tool For Improving Image Fusion Accuracy: How Does It Work And Why Does It Help
  Presenter(s):Cynthia K. Shortell, MD  
  View Slides in PDF      
10:34 AM - 10:39 AM The Cydar System’s Value In Standard And Complex EVAR
  Presenter(s):Venkatesh G. Ramaiah, MD  
  View Slides in PDF      
10:40 AM - 10:50 AM Panel Discussion
END OF SESSION 83
 
SESSION 84 SCHEDULE
Friday
SESSION 84: CHALLENGING RECORDED LIVE CASES FROM THE MAYO CLINIC AND THE UNIVERSITY OF TEXAS, HOUSTON
x
10:50 AM - 11:00 AM Case 1: 45 Female With Loeys-Dietz Syndrome And Multiple Aortic Repairs
  Presenter(s):Guilherme B. Lima, MD  
  View Slides in PDF      
11:00 AM - 11:04 AM Panel Discussion
11:04 AM - 11:14 AM Case 2: 83-Year-Old Man With Ascending Aortic Pseudoaneurysm
  Presenter(s):Bernardo C. Mendes, MD  
  View Slides in PDF      
11:14 AM - 11:18 AM Panel Discussion
11:18 AM - 11:28 AM Case 3: 79 Female With Large Visceral Patch Aneurysm Following Open TAAA Repair
  Presenter(s):Naveed U. Saqib, MD, FACS  
  View Slides in PDF      
11:28 AM - 11:32 AM Panel Discussion
11:32 AM - 11:42 AM Case 4: 72-Year-Old Woman With Chronic Mesenteric Ischemia And Extent III TAAA
  Presenter(s):Bernardo C. Mendes, MD  
  View Slides in PDF      
11:42 AM - 11:46 AM Panel Discussion
11:46 AM - 11:56 AM Case 5: 71 Male With Aortic Arch Graft Pseudoaneurysm
  Presenter(s):Guilherme B. Lima, MD  
  View Slides in PDF      
11:56 AM - 12:00 PM Panel Discussion
12:00 PM - 1:15 PM Lunch Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 84
 
SESSION 85 SCHEDULE
Friday
SESSION 85: ONE PRESENTATION FROM MÜNSTER, GERMANY ON LOWER EXTREMITY STENTS
x
1:15 PM - 1:21 PM One Year Results Of The EMINENT RCT Comparing The Eluvia DES Versus Bare Metal Stents
  Presenter(s):Giovanni B. Torsello, MD  
  View Slides in PDF      
1:22 PM - 1:25 PM Discussion
END OF SESSION 85
 
SESSION 86 SCHEDULE
Friday
SESSION 86: NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
x
1:26 PM - 1:31 PM New Developments In The Treatment Of Neurogenic TOSs: What Preop Factors Correlate With Good Outcomes; With Bad Outcomes
  Presenter(s):Karl A. Illig, MD  
  View Slides in PDF      
1:32 PM - 1:37 PM

Power Point Presentation with Synched Audio
Supraclavicular Approach To Arterial And Neurogenic TOSs (Video Presentation)
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Slides in PDF      
VENOUS TOSs
1:38 PM - 1:43 PM Venous TOSs: Lessons Learned After Treating >1000 Cases
  Presenter(s):Robert W. Thompson, MD  
  View Slides in PDF      
1:44 PM - 1:49 PM Spectrum Of Treatment Options For Venous TOS: What Are The Outcomes And How Do They Differ
  Presenter(s):Jason T. Lee, MD  
  View Slides in PDF      
1:50 PM - 1:55 PM Venography And Balloon Angioplasty For Neurogenic Thoracic Outlet Syndrome: A New Diagnostic And Therapeutic Approach
  Presenter(s):Sam S. Ahn, MD, FACS, MBA  
  View Slides in PDF      
1:56 PM - 2:03 PM Technical Tips For Optimal Surgical Treatment For Venous TOS
  Presenter(s):Robert W. Thompson, MD  
  View Slides in PDF      
2:04 PM - 2:14 PM Panel Discussion
2:14 PM - 2:30 PM Break – Visit Exhibits And Pavilions (North, West, Center and South Foyers)
END OF SESSION 86
 
SESSION 87 SCHEDULE
Friday
SESSION 87: NEW DEVELOPMENTS IN MEDICAL AND DRUG TREATMENTS: BEST ANTIPLATELET REGIMENS; UPDATE ON RARE VASCULAR DISEASES
x
ANTIPLATELET REGIMENS
2:30 PM - 2:35 PM

Power Point Presentation with Synched Audio
Optimal Antiplatelet Management With CEAs, Lower Extremity Bypasses And Open AAA Repairs
  Presenter(s):David H. Stone, MD  
  View Slides in PDF      
2:36 PM - 2:41 PM Optimal Anticoagulation And Antiplatelet Treatment For High Risk Lower Extremity Bypasses – Vein And PTFE
  Presenter(s):Peter Henke, MD  
  View Slides in PDF      
2:42 PM - 2:47 PM Most Effective Antiplatelet After Lower Extremity Interventional Treatments For CLTI – POBA, DCBs, Stents, Etc.
  Presenter(s):Maciej L. Dryjski , MD, PhD  
  View Slides in PDF      
2:48 PM - 2:53 PM Why Clopidogrel Is Effective In <50% Of Patients At Standard Doses: How To Identify And Fix This Problem
  Presenter(s):Karthik Kasirajan, MD  
  View Slides in PDF      
NEW DEVELOPMENTS IN LIPID MANAGEMENT – STATINS
2:54 PM - 2:59 PM Safety And Benefit Of Statins And Medical Treatment In Vascular Patients: Shockingly These Treatments Are Underutilized – Especially In Women: Why Is This So
  Presenter(s):Christian A. Behrendt, MD  
  View Slides in PDF      
3:00 PM - 3:05 PM Value Of Statins In AAA Patients After Repair: Long-Term Impact On Mortality
  Presenter(s):Adam Beck, MD  
  View Slides in PDF      
3:06 PM - 3:11 PM The Importance Of Lipoprotein Little a [Lp(a)] Levels In Determining Atherosclerotic Risk: When Should It Be Measured And If High, How Treated: Do PCSK-9 Inhibitors Help
  Presenter(s):Caron B. Rockman, MD / Jeffrey S. Berger, MD, MS, FAHA, FACC   
  View Slides in PDF      
3:12 PM - 3:18 PM Panel Discussion
3:18 PM - 3:23 PM Elevated Neutrophil To Lymphocyte Ratio Predicts Poor Outcomes And Mortality After Elective EVAR And CEA: What Is The Mechanism
  Presenter(s):Jae S. Cho, MD  
  View Slides in PDF      
3:24 PM - 3:29 PM The Justification For Carotid Screening Is To Promote Medical Treatment To Decrease Stroke And MI Risks, Not To Push Patients To Have Unnecessary Invasive Procedures
  Presenter(s):Kosmas I. Paraskevas, MD  
  View Slides in PDF      
3:30 PM - 3:35 PM Lowering LDL-C And Controlling Elevated Blood Pressure Can Lower Cardiovascular Risk 80%: Doing These Things Should Be A Lifetime Goal
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
  View Slides in PDF      
3:36 PM - 3:41 PM How To Make Operations For Complications Of Vascular Ehlers Danlos Syndrome Go Well
  Presenter(s):James H. Black, III, MD  
  View Slides in PDF      
3:42 PM - 3:48 PM Panel Discussion
END OF SESSION 87
 
SESSION 88 SCHEDULE
Friday
SESSION 88: ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMA
x
3:48 PM - 3:53 PM Resuscitative Endovascular Balloon Occlusion Of The Aorta (REBOA): When Is It A Valuable Procedure And When Is It Not: Limitations And Precautions
  Presenter(s):Gilbert R. Upchurch, MD  
  View Slides in PDF      
3:54 PM - 3:59 PM Value Of REBOA For Pending And Actual Cardiac Arrest: What Is Partial And Intermittent REBOA And How Is It Helpful
  Presenter(s):Tal M. Hoerer, MD, PhD  
  View Slides in PDF      
4:00 PM - 4:05 PM Transexamic Acid – An Antifibrinolytic Drug: Does It Reduce Mortality With Mild To Moderate Traumatic Brain Injuries: Based On A RCT
  Presenter(s):Todd E. Rasmussen, MD, FACS  
  View Slides in PDF      
4:06 PM - 4:11 PM Why One Should Have A Stock On Hand Of Balloon-Expandable And Self- Expandable Covered Stents To Deal With Emergencies From Iatrogenic And Other Traumatic Vascular Injuries: What Should Be In The Stock
  Presenter(s):Maria A. Ruffino, MD, EBIR  
  View Slides in PDF      
4:12 PM - 4:17 PM Radial Access Techniques And Technology For Embolotherapy To Treat Vascular Trauma: Indications And Results
  Presenter(s):Jonathan J. Morrison, PhD, FRCS  
  View Slides in PDF      
4:18 PM - 4:23 PM For Major Venous Injuries: Repair Versus Ligation – Which Is Currently Best When
  Presenter(s):Samy S. Nitecki, MD  
  View Slides in PDF      
4:24 PM - 4:29 PM Update On Best Current Management Of Pediatric Vascular Injuries: When Conservative; When Open; When Endo And Precautions
  Presenter(s):Michael C. Dalsing, MD  
  View Slides in PDF      
4:30 PM - 4:38 PM Panel Discussion
BLUNT THORACIC AORTIC INJURY (BTAI)
4:38 PM - 4:43 PM Endovascular Repairs Of Traumatic Aortic Injuries – Civilian And Military: Technology, Technical Tips And Results
  Presenter(s):James W. Dennis, MD  
  View Slides in PDF      
4:44 PM - 4:49 PM When Can Minor BTAI Be Treated By Observation Without TEVAR: What Precautions Are Necessary
  Presenter(s):Elina Quiroga, MD, MPH  
  View Slides in PDF      
4:50 PM - 4:55 PM DEBATE: Are We Overtreating BTAI – Especially Lesser Injuries
  Presenter(s):Joseph J. DuBose, MD  
  View Slides in PDF      
4:56 PM - 5:01 PM DEBATE: Why Many Patients With Lesser Degrees Of BTAI Require TEVAR
  Presenter(s):Ali Azizzadeh, MD  
  View Slides in PDF      
5:02 PM - 5:07 PM Why Rapid And Complete Aortic Healing After TEVAR For BTAI Should Influence The Length And Diameter Of The Endograft Used: Oversizing And Length Of Seal Zone Can Be Minimized: Technical Tips
  Presenter(s):Shang Loh, MD  
  View Slides in PDF      
5:08 PM - 5:13 PM How To Manage Heparin In TEVAR For BTAI When Head Or Other Injuries Are Also Present: Some, None Or Just Sheath Flushing
  Presenter(s):Charles J. Fox, MD, FACS  
  View Slides in PDF      
5:14 PM - 5:19 PM With BTAI Requiring TEVAR, When Can The Left Subclavian Artery Be Covered And When Not: Tips On Endograft Sizing
  Presenter(s):Elina Quiroga, MD, MPH  
  View Slides in PDF      
5:20 PM - 5:30 PM Panel Discussion
END OF SESSION 88
 
SESSION 89 SCHEDULE
Friday
SESSION 89: PELVIC VENOUS DISORDERS, FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION
x
7:30 AM - 7:35 AM Venographic Techniques To Identify Pelvic Anatomy And Escape Points
  Presenter(s):Mark H. Meissner, MD  
  View Slides in PDF      
7:36 AM - 7:41 AM Iliocaval Duplex Ultrasound With Image Optimization
  Presenter(s):Jan M. Sloves, RVT  
  View Slides in PDF      
7:42 AM - 7:47 AM We Need Dedicated Venous Stents For Nutcracker Syndrome And We NeedThem Now
  Presenter(s):Peter Gloviczki, MD  
  View Slides in PDF      
7:48 AM - 7:53 AM Open Surgery For Nutcracker: Techniques And Results
  Presenter(s):Cynthia K. Shortell, MD  
  View Slides in PDF      
7:54 AM - 7:59 AM Ovarian Vein Embolization: Which Patient Benefits And Reimbursement
  Presenter(s):Kathleen D. Gibson, MD  
  View Slides in PDF      
8:00 AM - 8:05 AM Panel Discussion
END OF SESSION 89
 
SESSION 90 SCHEDULE
Friday
SESSION 90: CHRONIC VENOUS OBSTRUCTION
x
8:06 AM - 8:11 AM CAVA Trial Lessons Learned About Post Thrombotic Syndrome